array:24 [
  "pii" => "S2013251417302079"
  "issn" => "20132514"
  "doi" => "10.1016/j.nefroe.2017.11.017"
  "estado" => "S300"
  "fechaPublicacion" => "2018-01-01"
  "aid" => "376"
  "copyrightAnyo" => "2017"
  "documento" => "article"
  "crossmark" => 0
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia (English Version). 2018;38:79-86"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 3299
    "formatos" => array:3 [
      "EPUB" => 267
      "HTML" => 2367
      "PDF" => 665
    ]
  ]
  "Traduccion" => array:1 [
    "es" => array:20 [
      "pii" => "S0211699517300966"
      "issn" => "02116995"
      "doi" => "10.1016/j.nefro.2017.03.023"
      "estado" => "S300"
      "fechaPublicacion" => "2018-01-01"
      "aid" => "376"
      "copyright" => "Sociedad Española de Nefrología"
      "documento" => "article"
      "crossmark" => 0
      "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
      "subdocumento" => "fla"
      "cita" => "Nefrologia. 2018;38:79-86"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 6428
        "formatos" => array:3 [
          "EPUB" => 281
          "HTML" => 5392
          "PDF" => 755
        ]
      ]
      "es" => array:13 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Original breve</span>"
        "titulo" => "Efectos de la rotigotina sobre la sintomatolog&#237;a&#44; calidad de vida e higiene de sue&#241;o en el s&#237;ndrome de piernas inquietas en hemodi&#225;lisis"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "tieneResumen" => array:2 [
          0 => "es"
          1 => "en"
        ]
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "79"
            "paginaFinal" => "86"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Effects of rotigotine on clinical symptoms&#44; quality of life and sleep hygiene adequacy in haemodialysis-associated restless legs syndrome"
          ]
        ]
        "contieneResumen" => array:2 [
          "es" => true
          "en" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:7 [
            "identificador" => "fig0005"
            "etiqueta" => "Figura 1"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "gr1.jpeg"
                "Alto" => 1061
                "Ancho" => 1677
                "Tamanyo" => 61053
              ]
            ]
            "descripcion" => array:1 [
              "es" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Principal etiolog&#237;a de la enfermedad renal cr&#243;nica en pacientes con SPI en HD&#46; Resultados expresados en porcentajes &#40;&#37;&#41;&#46;</p> <p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">DM&#58; diabetes mellitus&#59; Enf&#46; AE&#58; enfermedad ateroemb&#243;lica&#59; Enf&#46; glomerular 1&#46;&#170;&#58; enfermedad glomerular primaria&#59; HTA&#58; hipertensi&#243;n arterial&#59; Nefropat&#237;a T-I&#58; nefropat&#237;a tubulointersticial&#59; SPI&#58; s&#237;ndrome de piernas inquietas&#46;</p>"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Vicent Esteve, Jose Carneiro, Gabriel Salazar, M&#243;nica Pou, Irati Tapia, Miquel Fulquet, Ver&#243;nica Duarte, Anna Saurina, F&#225;tima Moreno, Manel Ram&#237;rez de Arellano"
            "autores" => array:10 [
              0 => array:2 [
                "nombre" => "Vicent"
                "apellidos" => "Esteve"
              ]
              1 => array:2 [
                "nombre" => "Jose"
                "apellidos" => "Carneiro"
              ]
              2 => array:2 [
                "nombre" => "Gabriel"
                "apellidos" => "Salazar"
              ]
              3 => array:2 [
                "nombre" => "M&#243;nica"
                "apellidos" => "Pou"
              ]
              4 => array:2 [
                "nombre" => "Irati"
                "apellidos" => "Tapia"
              ]
              5 => array:2 [
                "nombre" => "Miquel"
                "apellidos" => "Fulquet"
              ]
              6 => array:2 [
                "nombre" => "Ver&#243;nica"
                "apellidos" => "Duarte"
              ]
              7 => array:2 [
                "nombre" => "Anna"
                "apellidos" => "Saurina"
              ]
              8 => array:2 [
                "nombre" => "F&#225;tima"
                "apellidos" => "Moreno"
              ]
              9 => array:2 [
                "nombre" => "Manel"
                "apellidos" => "Ram&#237;rez de Arellano"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S2013251417302079"
          "doi" => "10.1016/j.nefroe.2017.11.017"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251417302079?idApp=UINPBA000064"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699517300966?idApp=UINPBA000064"
      "url" => "/02116995/0000003800000001/v1_201801090621/S0211699517300966/v1_201801090621/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:20 [
    "pii" => "S201325141830021X"
    "issn" => "20132514"
    "doi" => "10.1016/j.nefroe.2017.05.017"
    "estado" => "S300"
    "fechaPublicacion" => "2018-01-01"
    "aid" => "398"
    "copyright" => "Sociedad Espa&#241;ola de Nefrolog&#237;a"
    "documento" => "simple-article"
    "crossmark" => 0
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "crp"
    "cita" => "Nefrologia &#40;English Version&#41;. 2018;38:87-91"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1991
      "formatos" => array:3 [
        "EPUB" => 234
        "HTML" => 1244
        "PDF" => 513
      ]
    ]
    "en" => array:12 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Case report</span>"
      "titulo" => "Hyponatremia in refractory congestive heart failure patients treated with icodextrin-based peritoneal dialysis&#58; A case series"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "87"
          "paginaFinal" => "91"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Hiponatremia en pacientes con insuficiencia card&#237;aca congestiva resistentes al tratamiento tratados con di&#225;lisis peritoneal con icodextrina&#58; una serie de casos"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Margarita Kunin, Liat Ganon, Eli J&#46; Holtzman, Dganit Dinour"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "Margarita"
              "apellidos" => "Kunin"
            ]
            1 => array:2 [
              "nombre" => "Liat"
              "apellidos" => "Ganon"
            ]
            2 => array:2 [
              "nombre" => "Eli J&#46;"
              "apellidos" => "Holtzman"
            ]
            3 => array:2 [
              "nombre" => "Dganit"
              "apellidos" => "Dinour"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S0211699517301339"
        "doi" => "10.1016/j.nefro.2017.05.010"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699517301339?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S201325141830021X?idApp=UINPBA000064"
    "url" => "/20132514/0000003800000001/v1_201802180616/S201325141830021X/v1_201802180616/en/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S2013251418300208"
    "issn" => "20132514"
    "doi" => "10.1016/j.nefroe.2018.01.008"
    "estado" => "S300"
    "fechaPublicacion" => "2018-01-01"
    "aid" => "388"
    "documento" => "article"
    "crossmark" => 0
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia &#40;English Version&#41;. 2018;38:73-8"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 4404
      "formatos" => array:3 [
        "EPUB" => 274
        "HTML" => 3352
        "PDF" => 778
      ]
    ]
    "en" => array:12 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>"
      "titulo" => "Hyperuricemia is associated with progression of chronic kidney disease in patients with reduced functioning kidney mass"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "73"
          "paginaFinal" => "78"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Fig&#46; 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1663
              "Ancho" => 1632
              "Tamanyo" => 158415
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Relationship between hyperuricemia &#40;&#62;7<span class="elsevierStyleHsp" style=""></span>mg&#47;dl of uric acid level&#41; and renal disease progression &#40;Cox regression model&#41;&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Isabel Gal&#225;n, Marian Goicoechea, Borja Quiroga, Nicol&#225;s Mac&#237;as, Alba Santos, Maria Soledad Garc&#237;a de Vinuesa, &#218;rsula Verdalles, Santiago Cede&#241;o, Eduardo Verde, Ana P&#233;rez de Jos&#233;, Ana Garc&#237;a, Jos&#233; Lu&#241;o"
          "autores" => array:12 [
            0 => array:2 [
              "nombre" => "Isabel"
              "apellidos" => "Gal&#225;n"
            ]
            1 => array:2 [
              "nombre" => "Marian"
              "apellidos" => "Goicoechea"
            ]
            2 => array:2 [
              "nombre" => "Borja"
              "apellidos" => "Quiroga"
            ]
            3 => array:2 [
              "nombre" => "Nicol&#225;s"
              "apellidos" => "Mac&#237;as"
            ]
            4 => array:2 [
              "nombre" => "Alba"
              "apellidos" => "Santos"
            ]
            5 => array:2 [
              "nombre" => "Maria Soledad"
              "apellidos" => "Garc&#237;a de Vinuesa"
            ]
            6 => array:2 [
              "nombre" => "&#218;rsula"
              "apellidos" => "Verdalles"
            ]
            7 => array:2 [
              "nombre" => "Santiago"
              "apellidos" => "Cede&#241;o"
            ]
            8 => array:2 [
              "nombre" => "Eduardo"
              "apellidos" => "Verde"
            ]
            9 => array:2 [
              "nombre" => "Ana"
              "apellidos" => "P&#233;rez de Jos&#233;"
            ]
            10 => array:2 [
              "nombre" => "Ana"
              "apellidos" => "Garc&#237;a"
            ]
            11 => array:2 [
              "nombre" => "Jos&#233;"
              "apellidos" => "Lu&#241;o"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S021169951730108X"
        "doi" => "10.1016/j.nefro.2017.04.006"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S021169951730108X?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251418300208?idApp=UINPBA000064"
    "url" => "/20132514/0000003800000001/v1_201802180616/S2013251418300208/v1_201802180616/en/main.assets"
  ]
  "en" => array:20 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Short Original</span>"
    "titulo" => "Effects of rotigotine on clinical symptoms&#44; quality of life and sleep hygiene adequacy in hemodialysis-associated restless legs syndrome"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "79"
        "paginaFinal" => "86"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Vicent Esteve, Jose Carneiro, Gabriel Salazar, M&#243;nica Pou, Irati Tapia, Miquel Fulquet, Ver&#243;nica Duarte, Anna Saurina, F&#225;tima Moreno, Manel Ram&#237;rez de Arellano"
        "autores" => array:10 [
          0 => array:4 [
            "nombre" => "Vicent"
            "apellidos" => "Esteve"
            "email" => array:1 [
              0 => "vesteve&#64;cst&#46;cat"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:2 [
            "nombre" => "Jose"
            "apellidos" => "Carneiro"
          ]
          2 => array:2 [
            "nombre" => "Gabriel"
            "apellidos" => "Salazar"
          ]
          3 => array:2 [
            "nombre" => "M&#243;nica"
            "apellidos" => "Pou"
          ]
          4 => array:2 [
            "nombre" => "Irati"
            "apellidos" => "Tapia"
          ]
          5 => array:2 [
            "nombre" => "Miquel"
            "apellidos" => "Fulquet"
          ]
          6 => array:2 [
            "nombre" => "Ver&#243;nica"
            "apellidos" => "Duarte"
          ]
          7 => array:2 [
            "nombre" => "Anna"
            "apellidos" => "Saurina"
          ]
          8 => array:2 [
            "nombre" => "F&#225;tima"
            "apellidos" => "Moreno"
          ]
          9 => array:2 [
            "nombre" => "Manel"
            "apellidos" => "Ram&#237;rez de Arellano"
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Servei Nefrologia i Neurologia&#44; Hospital de Terrassa&#44; Consorci Sanitari Terrassa &#40;CST&#41;&#44; Barcelona&#44; Spain"
            "identificador" => "aff0005"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "<span class="elsevierStyleItalic">Corresponding author</span>&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Efectos de la rotigotina sobre la sintomatolog&#237;a&#44; calidad de vida e higiene de sue&#241;o en el s&#237;ndrome de piernas inquietas en hemodi&#225;lisis"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Fig&#46; 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 1061
            "Ancho" => 1677
            "Tamanyo" => 60891
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Causes of chronic kidney disease in patients with RLS in HD&#46; Results expressed in percentages &#40;&#37;&#41;&#46; DM&#58; diabetes mellitus&#59; AE Dis&#46;&#58; atheroembolic disease&#59; primary glomerular Dis&#58; primary glomerular disease&#59; HTN&#58; hypertension&#59; TI nephropathy&#58; tubulointerstitial nephropathy&#59; RLS&#58; restless legs syndrome&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Restless legs syndrome &#40;RLS&#41; is an entity characterized by an uncontrollable impulse to move limbs&#44; especially lower limbs&#44; accompanied by discomfort or unpleasant sensations in these extremities &#40;such as itching&#44; tingling&#44; pain&#44; stretching&#44; etc&#46;&#41;&#46; This occurs after a period of rest and are improved or disappear with movement&#46;<a class="elsevierStyleCrossRefs" href="#bib0130"><span class="elsevierStyleSup">1&#44;2</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">The diagnosis is based on the symptoms observed and the prevalence in the general population is between 5 and 10&#37;&#59; it is more frequent in women and in advanced ages&#46;<a class="elsevierStyleCrossRefs" href="#bib0140"><span class="elsevierStyleSup">3&#44;4</span></a> Patients with RLS have an impairement in the quality of life&#44; with clinical manifestations of depression or anxiety&#44; as well as a deterioration of sleep habits with daytime sleepiness and fatigue&#46; Some studies even point out a direct relationship between RLS and an increase in mortality&#46;<a class="elsevierStyleCrossRefs" href="#bib0150"><span class="elsevierStyleSup">5&#8211;7</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">The alterations of hypothalamic dopaminergic cells in response to elevated levels of some neurotransmitters&#44; the reduction of inhibition at the level of the motor cortex&#44; the hyperreactivity of the spinal flexor reflex or alterations of brain stem reflexes have been some of the diverse and complex neurological mechanisms involved in the pathophysiology of this syndrome&#46;<a class="elsevierStyleCrossRefs" href="#bib0165"><span class="elsevierStyleSup">8&#8211;10</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">From the etiological point of view&#44; there are two forms of RLS primary or idiopathic and the secondary&#46; The secondary forms are related to many etiologies&#44; although the most frequent are those associated with anemia with iron deficiency&#44; diabetic neuropathy&#44; neurodegenerative diseases &#8211; such as multiple sclerosis or Parkinson&#39;s disease &#8211; and the presence of advanced chronic kidney disease&#46;<a class="elsevierStyleCrossRefs" href="#bib0180"><span class="elsevierStyleSup">11&#8211;13</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">Uremia related RLS is often underdiagnosed&#46; Its prevalence is variable and it is estimated to be between 12 and 30&#37;&#46; The prevalence is higher among patients included in renal replacement therapy programs&#44; mainly in hemodialysis &#40;HD&#41;&#46;<a class="elsevierStyleCrossRefs" href="#bib0150"><span class="elsevierStyleSup">5&#44;14&#44;15</span></a> However&#44; there are not many published studies and they do not include many patients and in some cases with contradictory information&#46;</p><p id="par0030" class="elsevierStylePara elsevierViewall">Currently&#44; the pharmacological therapy of SPI is based mainly on the use of non-ergotamine dopamine agonists&#46;<a class="elsevierStyleCrossRefs" href="#bib0195"><span class="elsevierStyleSup">14&#44;15</span></a> Its main advantage&#44; compared to the classic use of levodopa and gabapentin&#44; lies mainly in the occurrence of fewer gastrointestinal adverse events&#46; The most commonly used are pramipexole&#44; ropinirole and&#44; more recently&#44; rotigotine&#46;<a class="elsevierStyleCrossRefs" href="#bib0205"><span class="elsevierStyleSup">16&#8211;18</span></a> Rotigotine shows a better control of symptoms&#44; less incidence of both adverse effects and paradoxical potentiation of symptoms &#40;augmentation effect&#41; as well as an ease administration and dosing to the HD patient&#46;<a class="elsevierStyleCrossRef" href="#bib0215"><span class="elsevierStyleSup">18</span></a></p><p id="par0035" class="elsevierStylePara elsevierViewall">Given the potential impact of the treatment of RLS on the quality of life and the medical implications&#44; together with the absence of reporto n national series&#44; we thought it would be interesting to conduct this study to describe the prevalence of RLS in our HD unit as well as analyzing the possible effects of rotigotine on the symptoms&#44; quality of life and sleep disorder in our HD patients with RLS&#46;</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Methods</span><p id="par0040" class="elsevierStylePara elsevierViewall">During the months from January to April 2015&#44; a prospective&#44; 12-week&#44; single-center study was performed in patients with RLS included in regular HD in our center&#46; The study was approved by the Hospital Ethics and Clinical Research Committee and it was carried out in accordance with the Helsinki Declaration&#46;</p><p id="par0045" class="elsevierStylePara elsevierViewall">The inclusion criteria were the following&#58; age equal to or greater than 18 years&#44; with the diagnosis of RLS and signing the informed consent&#46; The exclusion criteria were&#58; lack of informed consent and intellectually unable to answer the questionnaire&#46;</p><p id="par0050" class="elsevierStylePara elsevierViewall">The periodic HD program of our hospital distributes patients in 6 groups of 10&#8211;12 patients&#46; These groups perform sessions only in the high-flux HD modality with a 3&#46;5&#8211;4<span class="elsevierStyleHsp" style=""></span>h duration on alternate days &#40;L-X-V or M-J-S&#41;&#44; during morning&#44; noon &#40;3&#46;5<span class="elsevierStyleHsp" style=""></span>h&#41; and afternoon shifts&#46;</p><p id="par0055" class="elsevierStylePara elsevierViewall">There were two comparative study phases with a duration of six weeks each&#46; In the first phase &#40;phase 1&#41;&#44; HD patients at our center were diagnosed of RLS according to the international clinical criteria of the International Restless Leg Syndrome Study Group &#40;IRLSSG&#44; 2012&#41; 1&#46; All patients with RLS were evaluated by the same neurologist&#46; Patients who met 4 criteria were diagnosed of RLS&#46; In the second phase &#40;phase 2&#41;&#44; transdermal patches of rotigotine were administered during the first 2 weeks of the week &#40;1<span class="elsevierStyleHsp" style=""></span>mg&#47;day&#41; and in case of correct tolerance and absence of adverse effects&#44; the dose was increased daily up to 2<span class="elsevierStyleHsp" style=""></span>mg&#47;day&#46; After an individualized explanation of the administration system&#44; rotigotine transdermal patches were maintained for 24<span class="elsevierStyleHsp" style=""></span>h&#44; with rotation of the application sites&#46; In case of requiring dose reduction&#44; this was done progressively to avoid a rebound effect on symptomatology&#46;</p><p id="par0060" class="elsevierStylePara elsevierViewall">At the beginning of the study&#44; main demographic data were collected &#40;age&#44; gender&#44; ethiology of renal failure&#44; vintage&#41; and associated comorbidities &#40;diabetes mellitus&#44; arterial hypertension&#44; peripheral vascular disease&#44; ischemic heart disease&#44; Charlson comorbidity index&#44; smoking&#44; alcohol habit&#44; caffeine derivatives&#41;&#46; Both at the beginning and at the end of each of phases&#44; the main biochemical data were analyzed&#44; the patient&#39;s usual medication related to RLS&#44; as well as the characteristics and adequacy data in HD &#40;Kt&#47;V&#44; method 2nd generation Daugirdas&#41;&#46; Also&#44; the following variables were analyzed&#46;</p><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Degree of severity of restless legs syndrome symptoms and questionnaire on specific symptoms</span><p id="par0065" class="elsevierStylePara elsevierViewall">The degree of severity of the symptoms was determined by the severity scale &#40;GRLS&#41; established by the IRLSSG19 and the symptomatology in both lower limbs by means of a questionnaire of specific symptoms &#40;QS&#41;&#46; The GRLS is a validated survey in relation to the repercussion of the SPI symptomatology in each patient&#46; It consists of 10 questions with 5 possible answers&#46; Each answer is scored from 0 to 4&#46; The simplest way to analyze the result is the sum of the total score&#46; From 15 points up&#44; it is considered severe symptomatology&#46; The higher the score&#44; the greater the severity&#46; The QS assesses using a qualitative scale &#40;1&#58; null&#44; 2&#8211;3&#58; little 4&#58; enough&#44; 5&#58; a lot&#41; the presence of the following symptoms&#58; muscle pain&#44; cramps&#44; tingling&#44; burning and numbness&#46;</p><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Quality of life and sleep habits</span><p id="par0070" class="elsevierStylePara elsevierViewall">Quality of life was assessed using an approved health questionnaire adapted to RLS&#58; John Hopkins RLS QoL &#40;JH-QoL&#41;&#46;<a class="elsevierStyleCrossRef" href="#bib0225"><span class="elsevierStyleSup">20</span></a> Includes 18 questions with 5 possible answers and a score from 0 to 4&#46; The simplest way to analyze the results is the sum of the total score&#46; Overall&#44; the higher the score&#44; the poorer quality of life for a RLS patient&#46; The sleep habit was evaluated using the validated SCOPA<a class="elsevierStyleCrossRef" href="#bib0230"><span class="elsevierStyleSup">21</span></a> survey&#46; It consists of 2 sections&#59; the first evaluates the nighttime sleep&#46; It consists of 6 questions&#44; 5 more specific and valued from 0 &#40;not&#41; to 3 &#40;much&#41; and a sixth question that is dedicated to global assessment with 7 possibilities from 0 &#40;very bad&#41; to 7 &#40;very good&#41;&#46; In the second section daytime sleepiness is assessed&#46; It consists of 6 specific questions valued from 0 &#40;never&#41; to 3 &#40;frequently&#41;&#46; The global analysis is done by the sum of points in each section &#40;nocturnal sleep&#47;daytime sleepiness&#41;&#46;</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Efficacy of the treatment&#44; therapeutic completion and adverse effects</span><p id="par0075" class="elsevierStylePara elsevierViewall">With regard to the effectiveness of the treatment&#44; a partial response was defined as a reduction of more than 20&#37; in the QS&#46; A complete response was defined as a reduction of more than 80&#37; in the QS and the presence of &#8220;zero&#8221; symptoms was defined by a score lower than 5 points in the QS&#46;</p><p id="par0080" class="elsevierStylePara elsevierViewall">Compliance with the treatment was evaluated by reviewing the transdermal patch at the beginning of the HD session&#46; Those patients who presented absence of the transdermal patch in 3 regular revisions were classified as noncompliant&#46;</p><p id="par0085" class="elsevierStylePara elsevierViewall">Adverse effects analyzed by anamnesis during the usual sessions of HD were&#58; allergic-type reactions in the area of application &#40;erythema or induration&#44; local pain&#44; pruritus&#41;&#44; headache&#44; drowsiness&#44; nausea&#44; vomiting&#44; dyspepsia&#44; hypertension and paradoxical potentiation of the symptoms &#40;augmentation effect&#41;&#46;</p><p id="par0090" class="elsevierStylePara elsevierViewall">The statistical analysis was performed using the SPSS program version 18&#46;0 &#40;SPSS Inc&#44; Chicago&#44; IL&#44; USA&#41;&#46; By Kolmogorov&#8211;Smirnov test the data did not present a normal distribution&#46; The quantitative variables were expressed by means and standard deviation&#46; The qualitative variables&#44; by percentage&#46; The quantitative data were compared using the Wilcoxon test for nonparametric related variables and the qualitative data using the McNemar test&#46; The intergroup analysis was carried out using the Mann&#8211;Whitney <span class="elsevierStyleItalic">U</span> test&#44; considering a <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;05 value as statistical significance&#46;</p></span></span></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Results</span><p id="par0095" class="elsevierStylePara elsevierViewall">A total of 66 patients prevalent in the HD program were analyzed&#46; Five were excluded &#40;3 had dementia&#44; one did not accept to participate and another patient had a psychiatric disorder&#41;&#46; Of the remaining 61 patients&#44; 14 were diagnosed with RLS&#44; with a prevalence of 22&#46;9&#37;&#46; During the study period there were 5 dropouts &#40;one due to cardiorespiratory arrest&#44; 3 due to revocation of informed consent and one due to malignant hematological disease&#41;&#44; none of dropouts was the related to the present study&#46; Of the 9 remaining patients&#44; 44&#46;4&#37; were men&#44; with an average age of 70&#46;2 years<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>9&#46;9 years and a mean time on HD of 111&#46;1<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>160&#46;8 months&#46; The average Charlson index was 10&#46;2<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>2&#46; The main comorbidities were&#58; arterial hypertension &#40;88&#46;9&#37;&#41;&#44; diabetes mellitus &#40;77&#46;8&#37;&#41;&#44; peripheral vascular disease &#40;55&#46;6&#37;&#41; and ischemic heart disease &#40;22&#46;2&#37;&#41;&#46; The main etiology of chronic kidney disease was diabetes mellitus &#40;44&#46;4&#37;&#41;&#46; The rest of the etiologies are shown in <a class="elsevierStyleCrossRef" href="#fig0005">Fig&#46; 1</a>&#46; Among the potential triggers&#44; 44&#46;4&#37; consumed caffeine derivatives on a regular basis&#44; 25&#37; had alcohol consumption and 35&#46;7&#37; had active smoking&#46;</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0100" class="elsevierStylePara elsevierViewall">No significant differences were observed in the main biochemical parameters and HD adequacy in both phases of the study &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#41;&#46; Similarly&#44; no changes were made in the patient&#39;s usual medication related to RLS during the study &#40;88&#46;9&#37; conventional analgesia&#44; 33&#46;3&#37; antidepressants or anxiolytics and 11&#46;1&#37; took opioids&#44; respectively&#41;&#46; No patient was taking levodopa&#44; clonidine&#44; gabapentin&#44; <span class="elsevierStyleSmallCaps">l</span>-carnitine or antiemetics&#46; The characteristics of the HD filter were maintained &#40;helixone 33&#37;&#44; polysulfone 44&#37;&#44; polysulfone hi-flow 11&#37;&#44; polyacrylonitrile 11&#37;&#41; and no relevant changes were observed in the usual treatment given during HD sessions throughout the study &#40;iron intravenous 77&#46;8 vs&#46; 72&#46;5&#37;&#44; erythropoietic agents 30&#46;9<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>11&#46;6 vs&#46; 28&#46;8<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>10&#46;4<span class="elsevierStyleHsp" style=""></span>mcg darbopoetin&#47;week&#41;&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0105" class="elsevierStylePara elsevierViewall">The values of the main variables analyzed in the different phases of the study are shown in <a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>&#46; Regarding the severity of the symptoms&#44; 73&#46;3&#37; had severe symptoms &#40;GRLS<span class="elsevierStyleHsp" style=""></span>&#62;<span class="elsevierStyleHsp" style=""></span>P15&#41;&#44; 35&#46;7&#37; reported cramping&#44; 28&#46;5&#37; numbness and 21&#46;4&#37; muscle pain and burning&#44; in the QS of the lower extremities&#46; No relevant changes were observed in the GRLS scale &#40;19&#46;1<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>9&#46;2 vs&#46; 21&#46;1<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>4&#46;2&#44; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;524&#41; or in the QS questionnaire &#40;9&#46;3<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1&#46;7 vs 10&#46;2<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>2&#46;4&#59; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;428&#41; during phase 1 of the study&#46;</p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia><p id="par0110" class="elsevierStylePara elsevierViewall">During phase 2 of the study&#44; we observed a significant improvement in GRLS &#40;21&#46;1<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>43 vs&#46; 5&#46;7<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>4&#46;6&#59; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;001&#41; and QS &#40;10&#46;2<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>2&#46;4 vs&#46; 5&#46;7<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1&#46;1&#59; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#62;<span class="elsevierStyleHsp" style=""></span>0&#46;004&#41; after the introduction of rotigotine treatment&#46; The dose of transdermal rotigotine administered was 2<span class="elsevierStyleHsp" style=""></span>mg&#47;day&#44; with complete therapeutic compliance&#46; A 88&#46;8&#37; of the patients responded to the treatment with rotigotine&#44; with an average reduction of 15&#46;2<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>17&#46;2 points in the GRLS scale at the end of phase 2 of the study&#46; A 77&#46;7&#37; presented a partial response &#40;reduction greater than 20&#37; QS&#41; and 11&#46;1&#37; presented a complete remission &#40;reduction greater than 80&#37; in QS&#41;&#46; A 55&#46;5&#37; reached &#8220;zero&#8221; symptoms&#44; defined by a score lower than 5 points in the QS&#46; No allergic reactions were observed in the application area&#46; Only one patient presented mild gastro intestinal intolerance in the form of dyspepsia&#44; which yielded after the reduction of rotigotine to 1<span class="elsevierStyleHsp" style=""></span>mg&#47;day&#46; None of the patients in our study presented augmentation effect&#46;</p><p id="par0115" class="elsevierStylePara elsevierViewall">As far as quality of life related to RLS and sleep habits&#44; we observed a worsening for the JH-QoL scales &#40;19&#46;8<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>43 vs&#46; 22&#46;1<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>4&#46;4&#59; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;096&#41; and SCOPA &#40;total 15&#46;1<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>5&#46;3 vs&#46; 16<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>5&#46;3&#44; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;124&#59; diurnal&#44; 5&#46;3<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>3&#46;6 vs&#46; 5&#46;5<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>3&#46;6&#44; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;368&#59; nocturnal 9&#46;8<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>2&#46;7 vs&#46; 10&#46;4<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>2&#46;7&#59; <span class="elsevierStyleItalic">p</span> 0&#46;347&#41; during phase 1 of the study&#44; although these results did not reach statistical significance&#46; Overall&#44; after the introduction of rotigotine &#40;phase 2&#41;&#44; we observed a significant improvement in terms of quality of life related to SPI &#40;JH-QoL 22&#46;1<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>4&#46;4 vs&#46; 4&#46;3<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>4&#46;1&#59; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;004&#41; and in the different sections of sleep habits &#40;total SCOPA 16<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>5&#46;3 vs&#46; 6&#46;7<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1&#46;9&#59; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;001&#59; diurnal 5&#46;5<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>3&#46;6 vs&#46; 1&#46;4<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>0&#46;7&#59; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;013&#59; nocturnal 10&#46;4<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>2&#46;7 vs&#46; 6&#46;1<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1&#46;1&#59; <span class="elsevierStyleItalic">p</span> 0&#46;001&#41;&#46;</p><p id="par0120" class="elsevierStylePara elsevierViewall"><a class="elsevierStyleCrossRef" href="#tbl0015">Table 3</a> shows the difference of means of the main variables in the different phases of the study&#46; There was a significant improvement in terms of severity of symptoms &#40;1&#46;8<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>8&#46;5 vs&#46; &#8722;13&#46;3<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>8&#46;7&#59; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;003&#41;&#44; presence of specific symptoms in the lower extremities &#40;0&#46;6<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>2&#46;4 vs&#46; &#8722;4&#46;2<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>3&#46;1&#59; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;004&#41;&#44; quality of life related to RLS &#40;2&#46;3<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1&#46;6 vs&#46; &#8722;12&#46;7<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>3&#46;8&#59; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;001&#41; and sleep habits &#40;total 0&#46;9<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1&#46;1 vs&#46; &#8722;9&#46;2<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>5&#46;3&#59; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;001&#59; diurnal 0&#46;2<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>0&#46;6 vs 4&#46;1<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>3&#46;9&#44; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;001&#44; nocturnal 0&#46;6<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>0&#46;7 vs&#46; &#8722;4&#46;4<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>2&#46;3&#44; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;001&#41;&#44; after the introduction of rotigotine&#46;</p><elsevierMultimedia ident="tbl0015"></elsevierMultimedia></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Discussion</span><p id="par0125" class="elsevierStylePara elsevierViewall">The results of our study show that the RLS is frequent in our HD unit&#46; In these patients&#44; the use of rotigotine improved the clinical symptoms&#44; quality of life and sleep habits&#59; it is a safe drug&#44; with minimal adverse effects and complete therapeutic compliance&#46;</p><p id="par0130" class="elsevierStylePara elsevierViewall">The prevalence of RLS in our HD unit&#44; it is practically the same as previously described in the literature<a class="elsevierStyleCrossRefs" href="#bib0145"><span class="elsevierStyleSup">4&#44;22</span></a>&#58; it ranges from 12 and 30&#37;&#44; despite the high comorbidity and prolonged time on HD&#46; Patients with RLS have a decreased in life quality with depression and anxiety as well as a abnormalities in sleep habits producing daytime sleepiness and fatigue&#46;<a class="elsevierStyleCrossRefs" href="#bib0150"><span class="elsevierStyleSup">5&#44;19&#44;20</span></a> These data are similar to those observed in our study&#44; in which more than 75&#46;5&#37; of patients had severe symptoms&#46; The presence of all these symptoms affected quality of life and sleep habits&#46;</p><p id="par0135" class="elsevierStylePara elsevierViewall">Currently&#44; therapy with non-ergotamine dopamine agonists has become the first-line of therapy for moderate-severe involvement of RLS&#46; The most commonly used medications are pramipexole&#44; ropinirole and&#44; more recently&#44; rotigotine&#46;<a class="elsevierStyleCrossRefs" href="#bib0200"><span class="elsevierStyleSup">15&#8211;17</span></a> However&#44; there are still few published work evaluating the best treatment of RLS in HD patients<a class="elsevierStyleCrossRef" href="#bib0240"><span class="elsevierStyleSup">23</span></a> &#40;<a class="elsevierStyleCrossRef" href="#tbl0020">Table 4</a>&#41;&#46;</p><elsevierMultimedia ident="tbl0020"></elsevierMultimedia><p id="par0140" class="elsevierStylePara elsevierViewall">Within this group of drugs&#44; the use of rotigotine has been extended in the every day practice due to the efficacy&#44; good tolerance&#44; few adverse effects&#44; low prevalence of paradoxical potentiation of symptoms or augmentation effect and no need for dose adjustment in CKD patients&#46;<a class="elsevierStyleCrossRefs" href="#bib0245"><span class="elsevierStyleSup">24&#44;25</span></a> These advantages are mainly due to the administration in the form of transdermal patch&#44; which guarantees a continuous delivery throughout the day achieving stable serum levels that minimize the possibility of accumulation and there is no need to monitor blood levels and adverse effects are uncommon&#46; In addition transdermal application facilitates therapeutic adherence&#44; by decreasing the number of tablets the majority of patients on multiple medications&#44; facilitating therapeutic compliance&#46; The draw back is the high cost&#44; superior to the rest of the non-ergotamine agonists&#46; In our study&#44; rotigotine was a safe and effective drug&#44; with minimal adverse effects and complete therapeutic compliance&#44; there were no dropouts and achieved a significant improvement in clinical symptoms&#44; quality of life related to RLS and sleep habits&#46;</p><p id="par0145" class="elsevierStylePara elsevierViewall">To date&#44; uremic RLS has been underestimated as evidenced by the fact that none of the patients diagnosed received specific treatment for RLS&#46; Among other reasons&#44; this was probably due to&#58; the fact that symptoms in the lower limbs could be attributed to other factors or associated comorbidities&#44; the scant interest by the medical staff due in part to the lack of physiopathological knowledge of this entity and the absence of an effective treatment free of relevant adverse effects&#46; All these aspects have lead to the use of various medications without clear guidelines&#44; based on the clinical experiences themselves or on a few published works&#46;</p><p id="par0150" class="elsevierStylePara elsevierViewall">There is a significant prevalence of RLS&#44; a pathology that causes significant symptomatology associated to deterioration of the quality of life&#44; without lack of specific abnormalities in blood count or biochemical parameters&#46; Based on the results obtained in this study we should consider establishing different strategies to assess the presence of RLS in our patients&#46;</p><p id="par0155" class="elsevierStylePara elsevierViewall">In this sense&#44; all the incident patients in our HD unit will be evaluated for RLS according to the clinical criteria of the IRLSSG&#46; Those cases with reasonable doubts will be discussed with the Neurology Service for a more exhaustive assessment&#46; In the same way&#44; the severity of the symptoms and the quality of life and sleep habits will be assessed by means of the tests described above and&#44; in addition the patient will receive dietetic advice and the appropriate medical treatment according to the individual clinical characteristics&#46;</p><p id="par0160" class="elsevierStylePara elsevierViewall">Within the multiple limitations of our study&#44; we must mention the small number of patients included which forced the use of nonparametric statistical tests&#44; as well as the short time of follow-up&#46; The sample size was conditioned by our limited population in HD&#44; while the 12-week period was established to avoid possible confounding effect derived from the usual changes in medications after the quarterly analytical determinations in our HD unit&#46; Therefore&#44; we cannot rule out the possibility that a longer period of followup could entail some change in relation to the effectiveness&#44; safety and tolerance of rotigotine&#46; Studies with a larger number of patients and longer duration would be necessary to confirm the benefits of rotigotine observed in our patients in HD&#46;</p><p id="par0165" class="elsevierStylePara elsevierViewall">In conclusion&#44; we can state that there is considerable prevalence RLS&#44; with an intense symptomatology and a deteriorated quality of life and sleep habits&#46; The use of rotigotine improved clinical symptoms&#44; quality of life and sleep habits in HD patients with RLS&#46; It proved to be a safe drug&#44; with minimal adverse effects and complete therapeutic compliance&#46; However&#44; future studies would be necessary to confirm the benefit of rotigotine in the HD population with RLS&#46;</p></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Conflicts of interest</span><p id="par0170" class="elsevierStylePara elsevierViewall">The authors declare that they have no conflicts of interest&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:10 [
        0 => array:3 [
          "identificador" => "xres985608"
          "titulo" => "Abstract"
          "secciones" => array:5 [
            0 => array:2 [
              "identificador" => "abst0005"
              "titulo" => "Background"
            ]
            1 => array:2 [
              "identificador" => "abst0010"
              "titulo" => "Objectives"
            ]
            2 => array:2 [
              "identificador" => "abst0015"
              "titulo" => "Material and methods"
            ]
            3 => array:2 [
              "identificador" => "abst0020"
              "titulo" => "Results"
            ]
            4 => array:2 [
              "identificador" => "abst0025"
              "titulo" => "Conclusions"
            ]
          ]
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec953256"
          "titulo" => "Keywords"
        ]
        2 => array:3 [
          "identificador" => "xres985607"
          "titulo" => "Resumen"
          "secciones" => array:5 [
            0 => array:2 [
              "identificador" => "abst0030"
              "titulo" => "Introducci&#243;n"
            ]
            1 => array:2 [
              "identificador" => "abst0035"
              "titulo" => "Objetivos"
            ]
            2 => array:2 [
              "identificador" => "abst0040"
              "titulo" => "Material y m&#233;todos"
            ]
            3 => array:2 [
              "identificador" => "abst0045"
              "titulo" => "Resultados"
            ]
            4 => array:2 [
              "identificador" => "abst0050"
              "titulo" => "Conclusiones"
            ]
          ]
        ]
        3 => array:2 [
          "identificador" => "xpalclavsec953255"
          "titulo" => "Palabras clave"
        ]
        4 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Introduction"
        ]
        5 => array:3 [
          "identificador" => "sec0010"
          "titulo" => "Methods"
          "secciones" => array:1 [
            0 => array:3 [
              "identificador" => "sec0015"
              "titulo" => "Degree of severity of restless legs syndrome symptoms and questionnaire on specific symptoms"
              "secciones" => array:2 [
                0 => array:2 [
                  "identificador" => "sec0020"
                  "titulo" => "Quality of life and sleep habits"
                ]
                1 => array:2 [
                  "identificador" => "sec0025"
                  "titulo" => "Efficacy of the treatment&#44; therapeutic completion and adverse effects"
                ]
              ]
            ]
          ]
        ]
        6 => array:2 [
          "identificador" => "sec0030"
          "titulo" => "Results"
        ]
        7 => array:2 [
          "identificador" => "sec0035"
          "titulo" => "Discussion"
        ]
        8 => array:2 [
          "identificador" => "sec0040"
          "titulo" => "Conflicts of interest"
        ]
        9 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2016-10-03"
    "fechaAceptado" => "2017-03-16"
    "PalabrasClave" => array:2 [
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec953256"
          "palabras" => array:3 [
            0 => "Restless legs syndrome"
            1 => "Hemodialysis"
            2 => "Rotigotine"
          ]
        ]
      ]
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec953255"
          "palabras" => array:3 [
            0 => "S&#237;ndrome de piernas inquietas"
            1 => "Hemodi&#225;lisis"
            2 => "Rotigotina"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "en" => array:3 [
        "titulo" => "Abstract"
        "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Background</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Restless legs syndrome &#40;RLS&#41; is a neurological disorder characterized by bothersome symptoms associated with impaired quality of life and sleep hygiene&#46; Rotigotine is a novel therapeutic alternative&#44; although few studies have been published in patients on hemodialysis &#40;HD&#41; with RLS treated with rotigotine&#46;</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Objectives</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">&#40;1&#41; To establish the prevalence of RLS in our HD unit&#46; &#40;2&#41; To evaluate the efficacy and safety profile of rotigotine and its effect on symptoms&#44; quality of life and sleep hygiene in our HD population with RLS&#46;</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Material and methods</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">A single-center&#44; 12-week prospective study&#46; Two stages &#40;6 weeks&#41;&#58; stage 1 &#40;no treatment&#41; and stage 2 &#40;rotigotine&#41;&#46; We analyzed&#58; &#40;1&#41; Demographic data&#44; biochemistry data&#44; HD suitability parameters and RLS medical treatment data&#46; &#40;2&#41; Lower extremity symptoms questionnaire &#40;QS&#41;&#46; &#40;3&#41; RLS severity symptoms scale &#40;SRLSS&#41;&#46; &#40;4&#41; RLS quality of life&#58; John Hopkins RLS-QoL &#40;JH-QoL&#41;&#46; &#40;5&#41; Sleep hygiene&#58; SCOPA Scale&#46;</p></span> <span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Results</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">We included 66 HD patients&#44; 14 with RLS&#59; 44&#46;4&#37; male&#44; 70&#46;2<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>9&#46;9 years and 111&#46;1<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>160&#46;8 months on HD and 22&#46;9&#37; RLS&#46; Exclusively in stage 2&#44; a significant improvement for QS &#40;10<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>2&#46;4 vs&#46; 5&#46;7<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1&#46;0&#41;&#44; SRLSS &#40;21<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>4 vs&#46; 5&#46;7<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>4&#46;6&#41;&#44; JH-QoL &#40;22&#46;1<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>4&#46;4 vs&#46; 4&#46;3<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>4&#46;0&#41; and SCOPA &#40;16<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>5&#46;3 vs&#46; 6&#46;7<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1&#46;9&#41; were observed&#46; A 77&#46;7 and 11&#46;1&#37;&#44; showed partial &#40;&#62;20&#37;&#41; and complete &#40;&#62;80&#37;&#41; remission&#44; respectively&#44; while 55&#46;5&#37; achieved &#8220;zero&#8221; symptoms&#46; Only one patient had gastrointestinal intolerance and none experienced augmentation effect&#46; No changes in biochemical data&#44; suitability for dialysis or medical treatment were found&#46; The inter-group analysis showed a significant improvement in relation to QS&#44; SRLSS&#44; JH-QoL and SCOPA in stage 2&#46;</p></span> <span id="abst0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Conclusions</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">RLS showed a considerable prevalence in our HD unit&#46; Rotigotine improved clinical symptoms&#44; quality of life and sleep hygiene in RLS patients on HD and was found to be a safe drug with minimal side effects and total therapeutic compliance&#46; Nevertheless&#44; future studies should be performed to confirm the benefits of rotigotine in RLS patients on hemodialysis&#46;</p></span>"
        "secciones" => array:5 [
          0 => array:2 [
            "identificador" => "abst0005"
            "titulo" => "Background"
          ]
          1 => array:2 [
            "identificador" => "abst0010"
            "titulo" => "Objectives"
          ]
          2 => array:2 [
            "identificador" => "abst0015"
            "titulo" => "Material and methods"
          ]
          3 => array:2 [
            "identificador" => "abst0020"
            "titulo" => "Results"
          ]
          4 => array:2 [
            "identificador" => "abst0025"
            "titulo" => "Conclusions"
          ]
        ]
      ]
      "es" => array:3 [
        "titulo" => "Resumen"
        "resumen" => "<span id="abst0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Introducci&#243;n</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">El s&#237;ndrome de piernas inquietas &#40;SPI&#41; es un trastorno neurol&#243;gico caracterizado por una molesta sintomatolog&#237;a&#44; asociado a deterioro de calidad de vida e higiene de sue&#241;o&#46; Rotigotina constituye una novedosa alternativa terap&#233;utica&#44; si bien existen escasos estudios publicados sobre rotigotina en pacientes en hemodi&#225;lisis &#40;HD&#41; con SPI&#46;</p></span> <span id="abst0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Objetivos</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">1&#46;- Establecer la prevalencia de SPI en nuestra unidad de HD&#46; 2&#46;- Evaluar la eficacia y el perfil de seguridad asociado a rotigotina as&#237; como su efecto sobre la sintomatolog&#237;a&#44; calidad de vida e higiene del sue&#241;o en nuestra poblaci&#243;n en HD con SPI&#46;</p></span> <span id="abst0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Material y m&#233;todos</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">Estudio unic&#233;ntrico&#44; prospectivo de 12 semanas de duraci&#243;n&#46; Dos fases &#40;6 semanas&#41;&#58; fase 1 &#40;no tratamiento&#41; y fase 2 &#40;rotigotina&#41;&#46; Analizamos&#58; 1&#46;- Datos demogr&#225;ficos&#44; bioqu&#237;micos&#44; par&#225;metros de adecuaci&#243;n de HD y tratamiento m&#233;dico relacionado con SPI&#46; 2&#46;- Cuestionario sobre s&#237;ntomas en extremidades inferiores &#40;QS&#41;&#46; 3&#46;- Escala de gravedad de los s&#237;ntomas &#40;GRLS&#41;&#46; 4&#46;- Calidad de vida SPI&#58; John Hopkins RLS-QoL &#40;JH-QoL&#41;&#46; 5&#46;- Higiene del sue&#241;o&#58; Escala SCOPA&#46;</p></span> <span id="abst0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Resultados</span><p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Se incluy&#243; a 66 pacientes en HD&#46; De ellos&#44; 14 con SPI&#59; el 44&#44;4&#37; eran hombres&#44; con 70&#44;2<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>9&#44;9 a&#241;os y 111&#44;1<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>160&#44;8 meses en HD&#46; El 22&#44;9&#37;&#44; con SPI&#46; &#218;nicamente en la fase 2 observamos una mejor&#237;a significativa para QS &#40;10<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>2&#44;4 vs&#46; 5&#44;7<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1&#44;0&#41;&#44; GRLS &#40;21<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>4 vs&#46; 5&#44;7<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>4&#44;6&#41;&#44; JH-QoL &#40;22&#44;1<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>4&#44;4 vs&#46; 4&#44;3<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>4&#44;0&#41; y SCOPA &#40;16<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>5&#44;3 vs&#46; 6&#44;7<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1&#44;9&#41;&#46; Un 77&#44;7 y un 11&#44;1&#37; presentaron remisi&#243;n parcial &#40;&#62;20&#37;&#41; y completa &#40;&#62;80&#37;&#41;&#44; respectivamente&#46; Un 55&#44;5&#37; alcanz&#243; sintomatolog&#237;a &#171;cero&#187;&#46; Un &#250;nico paciente present&#243; intolerancia digestiva y ninguno&#44; <span class="elsevierStyleItalic">augmentation efect</span>&#46; No observamos cambios en datos bioqu&#237;micos&#44; adecuaci&#243;n dial&#237;tica ni tratamiento m&#233;dico&#46; El an&#225;lisis intergrupos mostr&#243; una mejor&#237;a significativa en la fase 2 con relaci&#243;n a QS&#44; GRLSS&#44; JH-QoL y SCOPA&#46;</p></span> <span id="abst0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Conclusiones</span><p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">En nuestro estudio&#44; el SPI ur&#233;mico present&#243; una prevalencia considerable&#46; Rotigotina mejor&#243; la sintomatolog&#237;a cl&#237;nica&#44; la calidad de vida y la higiene de sue&#241;o en los pacientes con SPI en HD&#44; por lo que resulta ser un f&#225;rmaco seguro&#44; con m&#237;nimos efectos adversos y con cumplimento terap&#233;utico completo&#46; No obstante&#44; ser&#237;an necesarios futuros estudios para confirmar el beneficio de rotigotina en la poblaci&#243;n en HD con SPI&#46;</p></span>"
        "secciones" => array:5 [
          0 => array:2 [
            "identificador" => "abst0030"
            "titulo" => "Introducci&#243;n"
          ]
          1 => array:2 [
            "identificador" => "abst0035"
            "titulo" => "Objetivos"
          ]
          2 => array:2 [
            "identificador" => "abst0040"
            "titulo" => "Material y m&#233;todos"
          ]
          3 => array:2 [
            "identificador" => "abst0045"
            "titulo" => "Resultados"
          ]
          4 => array:2 [
            "identificador" => "abst0050"
            "titulo" => "Conclusiones"
          ]
        ]
      ]
    ]
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0015">Please cite this article as&#58; Esteve V&#44; Carneiro J&#44; Salazar G&#44; Pou M&#44; Tapia I&#44; Fulquet M&#44; et al&#46; Efectos de la rotigotina sobre la sintomatolog&#237;a&#44; calidad de vida e higiene de sue&#241;o en el s&#237;ndrome de piernas inquietas en hemodi&#225;lisis&#46; Nefrologia&#46; 2018&#59;38&#58;79&#8211;86&#46;</p>"
      ]
    ]
    "multimedia" => array:5 [
      0 => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Fig&#46; 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 1061
            "Ancho" => 1677
            "Tamanyo" => 60891
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Causes of chronic kidney disease in patients with RLS in HD&#46; Results expressed in percentages &#40;&#37;&#41;&#46; DM&#58; diabetes mellitus&#59; AE Dis&#46;&#58; atheroembolic disease&#59; primary glomerular Dis&#58; primary glomerular disease&#59; HTN&#58; hypertension&#59; TI nephropathy&#58; tubulointerstitial nephropathy&#59; RLS&#58; restless legs syndrome&#46;</p>"
        ]
      ]
      1 => array:8 [
        "identificador" => "tbl0005"
        "etiqueta" => "Table 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at1"
            "detalle" => "Table "
            "rol" => "short"
          ]
        ]
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">Phase 1 and phase 2 &#40;rotigotine 2<span class="elsevierStyleHsp" style=""></span>mg&#47;day&#41;&#58; results are expressed as mean &#40;standard deviation&#41;&#44; initial vs&#46; final&#46;</p><p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">Ca&#58; calcium&#59; Hs-CRP&#58; C-reactive protein&#59; i-PTH&#58; intact parathyroid hormone&#59; K&#58; potassium&#59; Kt&#47;V&#58; 2nd generation method Daurgirdas&#59; Mg&#58; magnesium&#59; P&#58; phosphorus&#59; VitD&#58; vitamin D&#46;</p><p id="spar0075" class="elsevierStyleSimplePara elsevierViewall">No significant differences were found between the groups studied&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="" valign="top" scope="col">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " colspan="2" align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Phase 1</th><th class="td" title="table-head  " colspan="2" align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Phase 2</th></tr><tr title="table-row"><th class="td" title="table-head  " align="" valign="top" scope="col" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Initial&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Final&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Initial&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Final&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry  " colspan="5" align="left" valign="top"><span class="elsevierStyleItalic">Biochemical data</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Urea&#44; mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">237&#46;2 &#40;80&#46;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">234&#46;7 &#40;85&#46;4&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">236&#46;6 &#40;85&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">238&#46;1 &#40;87&#46;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Glucose&#44; mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">153&#46;2 &#40;51&#46;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">155&#46;8 &#40;62&#46;4&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">152&#46;2 &#40;32&#46;1&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">155&#46;4 &#40;36&#46;1&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Creatinine&#44; mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">8&#46;1 &#40;2&#46;3&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">8&#46;2 &#40;3&#46;1&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">8&#46;2 &#40;2&#46;3&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">8&#46;1 &#40;2&#46;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>K&#44; mEq&#47;L&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">5&#46;2 &#40;0&#46;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">5&#46;5 &#40;1&#46;1&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">5&#46;1 &#40;0&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">5&#46;2 &#40;0&#46;7&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Ca&#44; mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">9&#46;2 &#40;0&#46;4&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">9&#46;2 &#40;0&#46;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">9&#46;2 &#40;0&#46;4&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">9&#46;3 &#40;0&#46;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>P&#44; mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">4&#46;4 &#40;1&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">4&#46;3 &#40;1&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">4&#46;4 &#40;1&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">4&#46;3 &#40;1&#46;1&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Mg&#44; mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1&#46;9 &#40;0&#46;9&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1&#46;9 &#40;0&#46;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1&#46;8 &#40;0&#46;7&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1&#46;9 &#40;0&#46;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>i-PTH&#44; pg&#47;ml&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">257&#46;6 &#40;189&#46;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">265&#46;8 &#40;196&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">264&#46;4 &#40;110&#46;7&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">258&#46;4 &#40;183&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>25-OH vitD&#44; ng&#47;ml&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">23&#46;3 &#40;8&#46;1&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">26&#46;7 &#40;11&#46;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">28&#46;2 &#40;13&#46;5&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">27&#46;1 &#40;7&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Albumin&#44; g&#47;dL&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">3&#46;7 &#40;0&#46;3&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">3&#46;7 &#40;0&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">3&#46;8 &#40;0&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">3&#46;7 &#40;0&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Prealbumin&#44; mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">28&#46;5 &#40;10&#46;5&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">28&#46;1 &#40;4&#46;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">29&#46;2 &#40;6&#46;7&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">29&#46;7 &#40;7&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Total cholesterol&#44; mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">143&#46;2 &#40;57&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">148&#46;1 &#40;59&#46;1&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">153&#46;2 &#40;34&#46;4&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">149&#46;9 &#40;34&#46;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>HDL cholesterol&#44; mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">42&#46;6 &#40;11&#46;1&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">41&#46;2 &#40;11&#46;9&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">42&#46;7 &#40;10&#46;3&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">41&#46;2 &#40;43&#46;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>LDL cholesterol&#44; mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">68&#46;7 &#40;42&#46;3&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">63&#46;4 &#40;49&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">67&#46;2 &#40;65&#46;4&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">65&#46;9 &#40;33&#46;7&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Triglycerides&#44; mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">156&#46;1 &#40;74&#46;1&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">158&#46;6 &#40;72&#46;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">157&#46;2 &#40;70&#46;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">157&#46;2 &#40;71&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="5" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="5" align="left" valign="top"><span class="elsevierStyleItalic">Hemogram</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Hemoglobin&#44; g&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">10&#46;8 &#40;1&#46;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">11&#46;1 &#40;0&#46;9&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">10&#46;5 &#40;1&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">10&#46;9 &#40;0&#46;7&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Ferritin&#44; ng&#47;ml&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">411&#46;6 &#40;210&#46;7&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">427&#46;2 &#40;267&#46;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">424&#46;1 &#40;204&#46;9&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">421&#46;9 &#40;300&#46;1&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Hs-CRP&#44; ng&#47;L&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">7&#46;8 &#40;1&#46;5&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">8&#46;1 &#40;1&#46;7&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">8&#46;1 &#40;1&#46;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">8&#46;3 &#40;1&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="5" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="5" align="left" valign="top"><span class="elsevierStyleItalic">Dialysis adequacy</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Weekly hours of HD&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">11&#46;1 &#40;0&#46;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">11&#46;1 &#40;0&#46;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">11&#46;1 &#40;0&#46;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">11&#46;1 &#40;0&#46;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Dose of dialysis&#44; Kt&#47;V&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1&#46;62 &#40;0&#46;4&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1&#46;63 &#40;0&#46;7&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1&#46;63 &#40;0&#46;5&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1&#46;62 &#40;0&#46;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1672130.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">Biochemical parameters and adequacy of hemodialysis&#46;</p>"
        ]
      ]
      2 => array:8 [
        "identificador" => "tbl0010"
        "etiqueta" => "Table 2"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at2"
            "detalle" => "Table "
            "rol" => "short"
          ]
        ]
        "tabla" => array:3 [
          "leyenda" => "<p id="spar0085" class="elsevierStyleSimplePara elsevierViewall">Phase 1 and phase 2 &#40;rotigotine 2<span class="elsevierStyleHsp" style=""></span>mg&#47;day&#41;&#58; Results expressed as mean &#40;standard deviation&#41;&#44; initial vs&#46; final&#46;</p><p id="spar0090" class="elsevierStyleSimplePara elsevierViewall">GRLS&#58; scale of severity of symptoms of the International Restless Leg Syndrome Study Group&#59; JH-QoL&#58; John Hopkins restless leg syndrome quality of life&#59; QS&#58; scale of symptoms of lower extremities&#59; SCOPA&#58; sleep habits scale&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="" valign="top" scope="col">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " colspan="2" align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Phase 1</th><th class="td" title="table-head  " colspan="2" align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Phase 2</th></tr><tr title="table-row"><th class="td" title="table-head  " align="" valign="top" scope="col" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Initial&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Final&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Initial&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Final&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">GRLS&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">19&#46;1 &#40;9&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">21&#46;1 &#40;4&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">21&#46;1 &#40;4&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">5&#46;7 &#40;4&#46;6&#41;<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">&#42;</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">QS&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">9&#46;3 &#40;1&#46;7&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">10&#46;2 &#40;2&#46;4&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">10&#46;2 &#40;2&#46;4&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">5&#46;7 &#40;1&#46;1&#41;<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">&#42;</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">JH-QoL&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">19&#46;8 &#40;9&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">22&#46;1 &#40;4&#46;4&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">22&#46;1 &#40;4&#46;4&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">4&#46;3 &#40;4&#46;1&#41;<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">&#42;</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">SCOPA total&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">15&#46;1 &#40;5&#46;3&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">16 &#40;5&#46;3&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">16 &#40;5&#46;3&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">6&#46;7 &#40;1&#46;9&#41;<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">&#42;</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">SCOPA day&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">5&#46;3 &#40;3&#46;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">5&#46;6 &#40;3&#46;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">5&#46;6 &#40;3&#46;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1&#46;4 &#40;0&#46;7&#41;<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">&#42;</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">SCOPA night&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">9&#46;8 &#40;2&#46;7&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">10&#46;4 &#40;2&#46;7&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">10&#46;4 &#40;2&#46;7&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">6&#46;1 &#40;1&#46;1&#41;<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">&#42;</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1672128.png"
              ]
            ]
          ]
          "notaPie" => array:1 [
            0 => array:3 [
              "identificador" => "tblfn0005"
              "etiqueta" => "&#42;"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Statistical significance&#58; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;05&#46;</p>"
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0080" class="elsevierStyleSimplePara elsevierViewall">Scale for severity of symptom &#40;GRLS&#41;&#44; lower extremity symptoms questionnaire &#40;QS&#41;&#44; quality of life related to RLS &#40;JH-QoL&#41; and sleep habits &#40;SCOPA&#41;&#46;</p>"
        ]
      ]
      3 => array:8 [
        "identificador" => "tbl0015"
        "etiqueta" => "Table 3"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at3"
            "detalle" => "Table "
            "rol" => "short"
          ]
        ]
        "tabla" => array:3 [
          "leyenda" => "<p id="spar0100" class="elsevierStyleSimplePara elsevierViewall">Analysis of the mean changes of the main variables between the study groups&#46; Results expressed as mean &#40;standard deviation&#41;&#46;</p><p id="spar0105" class="elsevierStyleSimplePara elsevierViewall">GRLS&#58; scale of severity of symptoms of the International Restless Leg Syndrome Study Group&#59; JH-QoL&#58; John Hopkins restless leg syndrome quality of life&#59; QS&#58; scale of symptoms of lower extremities&#59; SCOPA&#58; sleep habits scale&#46;</p><p id="spar0110" class="elsevierStyleSimplePara elsevierViewall">Analysis using the nonparametric statistical test <span class="elsevierStyleItalic">U</span> of Mann&#8211;Whitney&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="" valign="top" scope="col" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Phase 1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Phase 2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">GRLS&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1&#46;8 &#40;8&#46;5&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">&#8722;13&#46;3 &#40;8&#46;7&#41;<a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">&#42;</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">QS&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;6 &#40;2&#46;4&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">&#8722;4&#46;2 &#40;3&#46;1&#41;<a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">&#42;</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">JH-QoL&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">2&#46;3 &#40;1&#46;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">&#8722;12&#46;7 &#40;3&#46;8&#41;<a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">&#42;</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">SCOPA total&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;9 &#40;0&#46;9&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">&#8722;9&#46;2 &#40;5&#46;3&#41;<a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">&#42;</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">SCOPA day&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;2 &#40;0&#46;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">&#8722;4&#46;1 &#40;3&#46;9&#41;<a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">&#42;</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">SCOPA night&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;6 &#40;0&#46;7&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">&#8722;4&#46;4 &#40;2&#46;3&#41;<a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">&#42;</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1672131.png"
              ]
            ]
          ]
          "notaPie" => array:1 [
            0 => array:3 [
              "identificador" => "tblfn0010"
              "etiqueta" => "&#42;"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0010">Statistical significance&#58; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;05&#46;</p>"
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0095" class="elsevierStyleSimplePara elsevierViewall">Analysis of differences between study groups&#46;</p>"
        ]
      ]
      4 => array:8 [
        "identificador" => "tbl0020"
        "etiqueta" => "Table 4"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at4"
            "detalle" => "Table "
            "rol" => "short"
          ]
        ]
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0120" class="elsevierStyleSimplePara elsevierViewall">CGI&#58; clinical global impression&#59; LQ&#58; quality of life&#59; AE&#58; adverse effects&#59; USA UU&#58; United States&#59; GRLS&#58; symptom severity scale of the International Restless Leg Syndrome Study Group&#59; HD&#58; hemodialysis&#59; iv&#58; intravenous&#59; PLM&#58; periodic leg movements&#59; PSQI&#58; Pittsburgh Sleep Quality Index&#59; RLS-6&#58; Restless Leg Syndrome scale 6&#59; RLS&#58; restless legs syndrome&#59; AVS&#58; analog visual scale&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Author &#40;country&#44; year&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">n</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Intervention groups&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Weeks&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Variables being analyzed&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Main results&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Trenkwalder &#40;Germany&#44; 1995&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">28 &#40;11 HD&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Intervention&#58; madopar &#40;L-dopa 100<span class="elsevierStyleHsp" style=""></span>mg<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>benserazide 25<span class="elsevierStyleHsp" style=""></span>mg&#41;<br>Control&#58; placebo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Own questionnaire on severity of symptoms RLS&#44; PLM&#44; LQ &#40;Hamburger AVS&#41;&#44; CGI&#44; AE&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">L-dopa significantly improved the main variables analyzed&#44; without relevant adverse effects&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Thorp &#40;USA&#44; 2001&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">16&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Intervention&#58; gabapentin &#40;200&#8211;300<span class="elsevierStyleHsp" style=""></span>mg&#47;post-HD day&#41;<br>Control&#58; placebo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Own questionnaire on severity of symptoms&#44; AE&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2 patients abandoned due to lethargy attributed to gabapentin<br>Gabapentin was an effective drug in the treatment of RLS in HD patients&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Sloand &#40;USA&#44; 2004&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">25&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Intervention&#58; Fe dextran iv &#40;1&#46;000<span class="elsevierStyleHsp" style=""></span>mg&#41;<br>Control&#58; normal saline iv&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Severity of symptoms SPI &#40;Rochester&#41;&#44; biochemical data Iron kinetics&#44; AE&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Headache&#44; nausea and vomiting&#44; without differences between groups<br>Iron dextran was associated with improvement of RLS symptoms and elevation of iron levels&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Micozkadioglu &#40;Turkey&#44; 2004&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">15&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Intervention&#58; gabapentin &#40;200<span class="elsevierStyleHsp" style=""></span>mg&#47;post-HD day&#41;<br>Control&#58; levodopa 125<span class="elsevierStyleHsp" style=""></span>mg&#47;day&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">RLS-6&#44; CV &#40;SF-36&#41;&#44; Sleep quality &#40;PSQI&#41;&#44; AE&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">One patient left due to fatigue and syncope in gabapentin group<br>Significant reduction in gabapentin group&#58; RLS-6&#44; SF-36 and PSQI&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Pellecchia &#40;Italy&#44; 2004&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">11&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Intervention&#58; ropinirol &#40;0&#46;25&#8211;2<span class="elsevierStyleHsp" style=""></span>mg&#47;day&#41;<br>Control&#58; levodopa continuous release &#40;25&#47;100&#8211;50&#47;200<span class="elsevierStyleHsp" style=""></span>mg&#47;day&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">GRLS&#44; sleep period &#40;polysomnography&#41;&#44; AE&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Ropinirol was superior to continuous release of levodopa in the treatment of RLS&#44; without relevant AE&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Sagheb &#40;Iran&#44; 2012&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">60&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Intervention&#58; 4 groups of 15 patients&#58; vitamin C &#40;200<span class="elsevierStyleHsp" style=""></span>mg&#41; and vitamin E &#40;400<span class="elsevierStyleHsp" style=""></span>mg&#41;&#59; vitamin C &#40;200<span class="elsevierStyleHsp" style=""></span>mg&#41; and placebo&#59; vitamin E &#40;400<span class="elsevierStyleHsp" style=""></span>mg&#41; and placebo&#59; double blind&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">8&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">GRLS&#44; AE&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Short term improvement of GRLS with Vitamin C and E as well as their combination&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Dauviliers &#40;USA&#44; 2016&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">30&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Intervention rotigotine &#40;1&#8211;3<span class="elsevierStyleHsp" style=""></span>mg&#47;day&#41;<br>Control&#58; placebo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">PLM&#44; GRLS&#44; CGI&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Nausea and dyspepsia in vitamin groups&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1672129.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0115" class="elsevierStyleSimplePara elsevierViewall">Main randomized clinical trials with pharmacological intervention in patients with restless legs syndrome in renal replacement therapy&#46;</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0015"
          "bibliografiaReferencia" => array:25 [
            0 => array:3 [
              "identificador" => "bib0130"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Restless legs syndrome&#47;Willis-Ekbom disease diagnostic criteria&#58; updated International Restless Legs Syndrome Study Group &#40;IRLSSG&#41; consensus criteria &#8211; history&#44; rationale&#44; description&#44; and significance"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "R&#46;P&#46; Allen"
                            1 => "D&#46;L&#46; Picchietti"
                            2 => "D&#46; Garcia-Borreguero"
                            3 => "W&#46;G&#46; Ondo"
                            4 => "A&#46;S&#46; Walters"
                            5 => "J&#46;W&#46; Winkelman"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.sleep.2014.03.025"
                      "Revista" => array:6 [
                        "tituloSerie" => "Sleep Med"
                        "fecha" => "2014"
                        "volumen" => "15"
                        "paginaInicial" => "860"
                        "paginaFinal" => "873"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25023924"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0135"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Definition of restless legs syndrome&#44; how to diagnose it&#44; and how to differentiate it from RLS mimics"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "H&#46; Benes"
                            1 => "A&#46;S&#46; Walters"
                            2 => "R&#46;P&#46; Allen"
                            3 => "W&#46;A&#46; Hening"
                            4 => "R&#46; Kohnen"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/mds.21604"
                      "Revista" => array:7 [
                        "tituloSerie" => "Mov Disord"
                        "fecha" => "2007"
                        "volumen" => "22"
                        "numero" => "Suppl&#46; 18"
                        "paginaInicial" => "S401"
                        "paginaFinal" => "S408"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17566118"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0140"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Prevalence and disease burden of primary restless legs syndrome&#58; results of a general population survey in the United States"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "R&#46;P&#46; Allen"
                            1 => "M&#46; Bharmal"
                            2 => "M&#46; Calloway"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/mds.23430"
                      "Revista" => array:6 [
                        "tituloSerie" => "Mov Disord"
                        "fecha" => "2011"
                        "volumen" => "26"
                        "paginaInicial" => "114"
                        "paginaFinal" => "120"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21322022"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0145"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Restless legs syndrome symptoms in primary care&#58; a prevalence study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "D&#46;A&#46; Nichols"
                            1 => "R&#46;P&#46; Allen"
                            2 => "J&#46;H&#46; Grauke"
                            3 => "J&#46;B&#46; Brown"
                            4 => "M&#46;L&#46; Rice"
                            5 => "P&#46;R&#46; Hyde"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/archinte.163.19.2323"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Intern Med"
                        "fecha" => "2003"
                        "volumen" => "163"
                        "paginaInicial" => "2323"
                        "paginaFinal" => "2329"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14581252"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0150"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Restless legs syndrome&#58; diagnostic criteria&#44; special considerations&#44; and epidemiology&#46; A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "R&#46;P&#46; Allen"
                            1 => "D&#46; Picchietti"
                            2 => "W&#46;A&#46; Hening"
                            3 => "C&#46; Trenkwalder"
                            4 => "A&#46;S&#46; Walters"
                            5 => "J&#46; Montplaisi"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Sleep Med"
                        "fecha" => "2003"
                        "volumen" => "4"
                        "paginaInicial" => "101"
                        "paginaFinal" => "119"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14592341"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0155"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Restless legs syndrome&#47;Willis Ekbom disease&#58; evaluation and treatment"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "R&#46;P&#46; Allen"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.3109/09540261.2014.904279"
                      "Revista" => array:6 [
                        "tituloSerie" => "Int Rev Psychiatry"
                        "fecha" => "2014"
                        "volumen" => "26"
                        "paginaInicial" => "248"
                        "paginaFinal" => "262"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24892899"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0160"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Impact&#44; diagnosis and treatment of restless legs syndrome &#40;RLS&#41; in a primary care population&#58; the REST &#40;RLS epidemiology&#44; symptoms&#44; and treatment&#41; primary care study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "W&#46; Hening"
                            1 => "A&#46;S&#46; Walters"
                            2 => "R&#46;P&#46; Allen"
                            3 => "J&#46; Montplaisir"
                            4 => "A&#46; Myers"
                            5 => "L&#46; Ferini-Strambi"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.sleep.2004.03.006"
                      "Revista" => array:6 [
                        "tituloSerie" => "Sleep Med"
                        "fecha" => "2004"
                        "volumen" => "5"
                        "paginaInicial" => "237"
                        "paginaFinal" => "246"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15165529"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0165"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Restless legs syndrome&#58; a review of clinical and pathophysiologic features"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "R&#46;P&#46; Allen"
                            1 => "C&#46;J&#46; Earley"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Clin Neurophysiol"
                        "fecha" => "2001"
                        "volumen" => "18"
                        "paginaInicial" => "128"
                        "paginaFinal" => "147"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11435804"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0170"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Thalamic glutamate&#47;glutamine in restless legs syndrome&#58; increased and related to disturbed sleep"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "R&#46;P&#46; Allen"
                            1 => "P&#46;B&#46; Barker"
                            2 => "A&#46; Horsk&#225;"
                            3 => "C&#46;J&#46; Earley"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1212/WNL.0b013e318294b3f6"
                      "Revista" => array:6 [
                        "tituloSerie" => "Neurology"
                        "fecha" => "2013"
                        "volumen" => "80"
                        "paginaInicial" => "2028"
                        "paginaFinal" => "2034"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23624560"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0175"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Altered white matter integrity in primary restless legs syndrome patients&#58; diffusion tensor imaging study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "Y&#46; Chang"
                            1 => "J&#46;S&#46; Paik"
                            2 => "H&#46;J&#46; Lee"
                            3 => "H&#46;W&#46; Chang"
                            4 => "H-J&#46; Moon"
                            5 => "R&#46;P&#46; Allen"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1179/1743132814Y.0000000336"
                      "Revista" => array:6 [
                        "tituloSerie" => "Neurol Res"
                        "fecha" => "2014"
                        "volumen" => "36"
                        "paginaInicial" => "769"
                        "paginaFinal" => "774"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24620984"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0180"
              "etiqueta" => "11"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Prevalence and clinical characteristics of restless legs syndrome in diabetic peripheral neuropathy&#58; comparison with chronic osteoarthritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "Y&#46;W&#46; Cho"
                            1 => "G&#46;Y&#46; Na"
                            2 => "J&#46;G&#46; Lim"
                            3 => "S&#46;-H&#46; Kim"
                            4 => "H&#46;S&#46; Kim"
                            5 => "C&#46;J&#46; Earley"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.sleep.2013.09.013"
                      "Revista" => array:6 [
                        "tituloSerie" => "Sleep Med"
                        "fecha" => "2013"
                        "volumen" => "14"
                        "paginaInicial" => "1387"
                        "paginaFinal" => "1392"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24210603"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib0185"
              "etiqueta" => "12"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Ferritin subunits in CSF are decreased in restless legs syndrome"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "S&#46;L&#46; Clardy"
                            1 => "C&#46;J&#46; Earley"
                            2 => "R&#46;P&#46; Allen"
                            3 => "J&#46;L&#46; Beard"
                            4 => "J&#46;R&#46; Connor"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.lab.2005.06.011"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Lab Clin Med"
                        "fecha" => "2006"
                        "volumen" => "147"
                        "paginaInicial" => "67"
                        "paginaFinal" => "73"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16459164"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib0190"
              "etiqueta" => "13"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Clinical characteristics of leg restlessness in Parkinson&#39;s disease compared with idiopathic restless legs syndrome"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "X&#46;-Y&#46; Zhu"
                            1 => "Y&#46; Liu"
                            2 => "X&#46;-J&#46; Zhang"
                            3 => "W&#46;-H&#46; Yang"
                            4 => "Y&#46; Feng"
                            5 => "W&#46;G&#46; Ondo"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jns.2015.07.008"
                      "Revista" => array:7 [
                        "tituloSerie" => "J Neurol Sci"
                        "fecha" => "2015"
                        "volumen" => "357"
                        "numero" => "1&#8211;2"
                        "paginaInicial" => "109"
                        "paginaFinal" => "114"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26189051"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib0195"
              "etiqueta" => "14"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A 10-year&#44; longitudinal assessment of dopamine agonists and methadone in the treatment of restless legs syndrome"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "N&#46; Silver"
                            1 => "R&#46;P&#46; Allen"
                            2 => "J&#46; Senerth"
                            3 => "C&#46;J&#46; Earley"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.sleep.2010.11.002"
                      "Revista" => array:6 [
                        "tituloSerie" => "Sleep Med"
                        "fecha" => "2011"
                        "volumen" => "12"
                        "paginaInicial" => "440"
                        "paginaFinal" => "444"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21239226"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib0200"
              "etiqueta" => "15"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Guidelines for the first-line treatment of restless legs syndrome&#47;Willis-Ekbom disease&#44; prevention and treatment of dopaminergic augmentation&#58; a combined task force of the IRLSSG&#44; EURLSSG&#44; and the RLS-foundation"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "D&#46; Garcia-Borreguero"
                            1 => "M&#46;H&#46; Silber"
                            2 => "J&#46;W&#46; Winkelman"
                            3 => "B&#46; H&#246;gl"
                            4 => "J&#46; Bainbridge"
                            5 => "M&#46; Buchfuhrer"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.sleep.2016.01.017"
                      "Revista" => array:6 [
                        "tituloSerie" => "Sleep Med"
                        "fecha" => "2016"
                        "volumen" => "21"
                        "paginaInicial" => "1"
                        "paginaFinal" => "11"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27448465"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib0205"
              "etiqueta" => "16"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Clinical efficacy of ropinirole for restless legs syndrome is not affected by age at symptom onset"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "R&#46;P&#46; Allen"
                            1 => "S&#46;Y&#46; Ritchie"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.sleep.2007.08.017"
                      "Revista" => array:6 [
                        "tituloSerie" => "Sleep Med"
                        "fecha" => "2008"
                        "volumen" => "9"
                        "paginaInicial" => "899"
                        "paginaFinal" => "902"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18024167"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            16 => array:3 [
              "identificador" => "bib0210"
              "etiqueta" => "17"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy and augmentation during 6 months of double-blind pramipexole for restless legs syndrome"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "B&#46; H&#246;gl"
                            1 => "D&#46; Garcia-Borreguero"
                            2 => "C&#46; Trenkwalder"
                            3 => "L&#46; Ferini-Strambi"
                            4 => "W&#46; Hening"
                            5 => "W&#46; Poewe"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.sleep.2010.12.007"
                      "Revista" => array:6 [
                        "tituloSerie" => "Sleep Med"
                        "fecha" => "2011"
                        "volumen" => "12"
                        "paginaInicial" => "351"
                        "paginaFinal" => "360"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21354368"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            17 => array:3 [
              "identificador" => "bib0215"
              "etiqueta" => "18"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Rotigotine improves restless legs syndrome&#58; a 6-month randomized&#44; double-blind&#44; placebo-controlled trial in the United States"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "W&#46;A&#46; Hening"
                            1 => "R&#46;P&#46; Allen"
                            2 => "W&#46;G&#46; Ondo"
                            3 => "A&#46;S&#46; Walters"
                            4 => "J&#46;W&#46; Winkelman"
                            5 => "P&#46; Becker"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/mds.23157"
                      "Revista" => array:6 [
                        "tituloSerie" => "Mov Disord"
                        "fecha" => "2010"
                        "volumen" => "25"
                        "paginaInicial" => "1675"
                        "paginaFinal" => "1683"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20629075"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            18 => array:3 [
              "identificador" => "bib0220"
              "etiqueta" => "19"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Relation of the International Restless Legs Syndrome Study Group rating scale with the Clinical Global Impression Severity Scale&#44; the Restless Legs Syndrome 6-Item Questionnaire&#44; and the Restless Legs Syndrome-Quality of life Questionnaire"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "R&#46; Allen"
                            1 => "W&#46; Oertel"
                            2 => "A&#46; Walters"
                            3 => "H&#46; Benes"
                            4 => "E&#46; Schollmayer"
                            5 => "F&#46; Grieger"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.sleep.2013.09.008"
                      "Revista" => array:6 [
                        "tituloSerie" => "Sleep Med"
                        "fecha" => "2013"
                        "volumen" => "14"
                        "paginaInicial" => "1375"
                        "paginaFinal" => "1380"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24246378"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            19 => array:3 [
              "identificador" => "bib0225"
              "etiqueta" => "20"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The Johns Hopkins telephone diagnostic interview for the restless legs syndrome&#58; preliminary investigation for validation in a multi-center patient and control population"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "W&#46;A&#46; Hening"
                            1 => "R&#46;P&#46; Allen"
                            2 => "S&#46; Thanner"
                            3 => "T&#46; Washburn"
                            4 => "D&#46; Heckler"
                            5 => "A&#46;S&#46; Walters"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Sleep Med"
                        "fecha" => "2003"
                        "volumen" => "4"
                        "paginaInicial" => "137"
                        "paginaFinal" => "141"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14592344"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            20 => array:3 [
              "identificador" => "bib0230"
              "etiqueta" => "21"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The Swedish SCOPA-SLEEP for assessment of sleep disorders in Parkinson&#39;s disease and healthy controls"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "P&#46; Hagell"
                            1 => "A&#46; Westergren"
                            2 => "S&#46; Janelidze"
                            3 => "O&#46; Hansson"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s11136-016-1318-2"
                      "Revista" => array:6 [
                        "tituloSerie" => "Qual Life Res"
                        "fecha" => "2016"
                        "volumen" => "25"
                        "paginaInicial" => "2571"
                        "paginaFinal" => "2577"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27198749"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            21 => array:3 [
              "identificador" => "bib0235"
              "etiqueta" => "22"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Restless legs syndrome prevalence and impact&#58; REST general population study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "R&#46;P&#46; Allen"
                            1 => "A&#46;S&#46; Walters"
                            2 => "J&#46; Montplaisir"
                            3 => "W&#46; Hening"
                            4 => "A&#46; Myers"
                            5 => "T&#46;J&#46; Bell"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/archinte.165.11.1286"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Intern Med"
                        "fecha" => "2005"
                        "volumen" => "165"
                        "paginaInicial" => "1286"
                        "paginaFinal" => "1292"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15956009"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            22 => array:3 [
              "identificador" => "bib0240"
              "etiqueta" => "23"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Interventions for chronic kidney disease-associated restless legs syndrome"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "S&#46; Gopaluni"
                            1 => "M&#46; Sherif"
                            2 => "N&#46;A&#46; Ahmadouk"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/14651858.CD011360.pub2"
                      "Revista" => array:4 [
                        "tituloSerie" => "Cochrane Database Syst Rev"
                        "fecha" => "2016"
                        "volumen" => "11"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27886368"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            23 => array:3 [
              "identificador" => "bib0245"
              "etiqueta" => "24"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Clinical pharmacology and efficacy of rotigotine &#40;Neupro<span class="elsevierStyleSup">&#174;</span> patch&#41; in the treatment of restless leg syndrome"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "L&#46; Ferini-Strambi"
                            1 => "S&#46; Marelli"
                            2 => "A&#46; Galbiati"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1080/17425255.2016.1194393"
                      "Revista" => array:6 [
                        "tituloSerie" => "Expert Opin Drug Metab Toxicol"
                        "fecha" => "2016"
                        "volumen" => "12"
                        "paginaInicial" => "967"
                        "paginaFinal" => "975"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27224246"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            24 => array:3 [
              "identificador" => "bib0250"
              "etiqueta" => "25"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Rotigotine in hemodialysis-associated restless legs syndrome&#58; a randomized controlled trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "Y&#46; Dauvilliers"
                            1 => "H&#46; Benes"
                            2 => "M&#46; Partinen"
                            3 => "V&#46; Rauta"
                            4 => "D&#46; Rifkin"
                            5 => "E&#46; Dohin"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1053/j.ajkd.2015.12.027"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Kidney Dis"
                        "fecha" => "2016"
                        "volumen" => "68"
                        "paginaInicial" => "434"
                        "paginaFinal" => "443"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26851201"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/20132514/0000003800000001/v1_201802180616/S2013251417302079/v1_201802180616/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "42660"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Original articles"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/20132514/0000003800000001/v1_201802180616/S2013251417302079/v1_201802180616/en/main.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251417302079?idApp=UINPBA000064"
]
Share
Journal Information

Statistics

Follow this link to access the full text of the article

Short Original
Effects of rotigotine on clinical symptoms, quality of life and sleep hygiene adequacy in hemodialysis-associated restless legs syndrome
Efectos de la rotigotina sobre la sintomatología, calidad de vida e higiene de sueño en el síndrome de piernas inquietas en hemodiálisis
Vicent Esteve
Corresponding author
vesteve@cst.cat

Corresponding author.
, Jose Carneiro, Gabriel Salazar, Mónica Pou, Irati Tapia, Miquel Fulquet, Verónica Duarte, Anna Saurina, Fátima Moreno, Manel Ramírez de Arellano
Servei Nefrologia i Neurologia, Hospital de Terrassa, Consorci Sanitari Terrassa (CST), Barcelona, Spain
Read
8527
Times
was read the article
2577
Total PDF
5950
Total HTML
Share statistics
 array:24 [
  "pii" => "S2013251417302079"
  "issn" => "20132514"
  "doi" => "10.1016/j.nefroe.2017.11.017"
  "estado" => "S300"
  "fechaPublicacion" => "2018-01-01"
  "aid" => "376"
  "copyrightAnyo" => "2017"
  "documento" => "article"
  "crossmark" => 0
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia &#40;English Version&#41;. 2018;38:79-86"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 3299
    "formatos" => array:3 [
      "EPUB" => 267
      "HTML" => 2367
      "PDF" => 665
    ]
  ]
  "Traduccion" => array:1 [
    "es" => array:20 [
      "pii" => "S0211699517300966"
      "issn" => "02116995"
      "doi" => "10.1016/j.nefro.2017.03.023"
      "estado" => "S300"
      "fechaPublicacion" => "2018-01-01"
      "aid" => "376"
      "copyright" => "Sociedad Espa&#241;ola de Nefrolog&#237;a"
      "documento" => "article"
      "crossmark" => 0
      "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
      "subdocumento" => "fla"
      "cita" => "Nefrologia. 2018;38:79-86"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 6428
        "formatos" => array:3 [
          "EPUB" => 281
          "HTML" => 5392
          "PDF" => 755
        ]
      ]
      "es" => array:13 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Original breve</span>"
        "titulo" => "Efectos de la rotigotina sobre la sintomatolog&#237;a&#44; calidad de vida e higiene de sue&#241;o en el s&#237;ndrome de piernas inquietas en hemodi&#225;lisis"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "tieneResumen" => array:2 [
          0 => "es"
          1 => "en"
        ]
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "79"
            "paginaFinal" => "86"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Effects of rotigotine on clinical symptoms&#44; quality of life and sleep hygiene adequacy in haemodialysis-associated restless legs syndrome"
          ]
        ]
        "contieneResumen" => array:2 [
          "es" => true
          "en" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:7 [
            "identificador" => "fig0005"
            "etiqueta" => "Figura 1"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "gr1.jpeg"
                "Alto" => 1061
                "Ancho" => 1677
                "Tamanyo" => 61053
              ]
            ]
            "descripcion" => array:1 [
              "es" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Principal etiolog&#237;a de la enfermedad renal cr&#243;nica en pacientes con SPI en HD&#46; Resultados expresados en porcentajes &#40;&#37;&#41;&#46;</p> <p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">DM&#58; diabetes mellitus&#59; Enf&#46; AE&#58; enfermedad ateroemb&#243;lica&#59; Enf&#46; glomerular 1&#46;&#170;&#58; enfermedad glomerular primaria&#59; HTA&#58; hipertensi&#243;n arterial&#59; Nefropat&#237;a T-I&#58; nefropat&#237;a tubulointersticial&#59; SPI&#58; s&#237;ndrome de piernas inquietas&#46;</p>"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Vicent Esteve, Jose Carneiro, Gabriel Salazar, M&#243;nica Pou, Irati Tapia, Miquel Fulquet, Ver&#243;nica Duarte, Anna Saurina, F&#225;tima Moreno, Manel Ram&#237;rez de Arellano"
            "autores" => array:10 [
              0 => array:2 [
                "nombre" => "Vicent"
                "apellidos" => "Esteve"
              ]
              1 => array:2 [
                "nombre" => "Jose"
                "apellidos" => "Carneiro"
              ]
              2 => array:2 [
                "nombre" => "Gabriel"
                "apellidos" => "Salazar"
              ]
              3 => array:2 [
                "nombre" => "M&#243;nica"
                "apellidos" => "Pou"
              ]
              4 => array:2 [
                "nombre" => "Irati"
                "apellidos" => "Tapia"
              ]
              5 => array:2 [
                "nombre" => "Miquel"
                "apellidos" => "Fulquet"
              ]
              6 => array:2 [
                "nombre" => "Ver&#243;nica"
                "apellidos" => "Duarte"
              ]
              7 => array:2 [
                "nombre" => "Anna"
                "apellidos" => "Saurina"
              ]
              8 => array:2 [
                "nombre" => "F&#225;tima"
                "apellidos" => "Moreno"
              ]
              9 => array:2 [
                "nombre" => "Manel"
                "apellidos" => "Ram&#237;rez de Arellano"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S2013251417302079"
          "doi" => "10.1016/j.nefroe.2017.11.017"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251417302079?idApp=UINPBA000064"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699517300966?idApp=UINPBA000064"
      "url" => "/02116995/0000003800000001/v1_201801090621/S0211699517300966/v1_201801090621/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:20 [
    "pii" => "S201325141830021X"
    "issn" => "20132514"
    "doi" => "10.1016/j.nefroe.2017.05.017"
    "estado" => "S300"
    "fechaPublicacion" => "2018-01-01"
    "aid" => "398"
    "copyright" => "Sociedad Espa&#241;ola de Nefrolog&#237;a"
    "documento" => "simple-article"
    "crossmark" => 0
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "crp"
    "cita" => "Nefrologia &#40;English Version&#41;. 2018;38:87-91"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1991
      "formatos" => array:3 [
        "EPUB" => 234
        "HTML" => 1244
        "PDF" => 513
      ]
    ]
    "en" => array:12 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Case report</span>"
      "titulo" => "Hyponatremia in refractory congestive heart failure patients treated with icodextrin-based peritoneal dialysis&#58; A case series"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "87"
          "paginaFinal" => "91"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Hiponatremia en pacientes con insuficiencia card&#237;aca congestiva resistentes al tratamiento tratados con di&#225;lisis peritoneal con icodextrina&#58; una serie de casos"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Margarita Kunin, Liat Ganon, Eli J&#46; Holtzman, Dganit Dinour"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "Margarita"
              "apellidos" => "Kunin"
            ]
            1 => array:2 [
              "nombre" => "Liat"
              "apellidos" => "Ganon"
            ]
            2 => array:2 [
              "nombre" => "Eli J&#46;"
              "apellidos" => "Holtzman"
            ]
            3 => array:2 [
              "nombre" => "Dganit"
              "apellidos" => "Dinour"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S0211699517301339"
        "doi" => "10.1016/j.nefro.2017.05.010"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699517301339?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S201325141830021X?idApp=UINPBA000064"
    "url" => "/20132514/0000003800000001/v1_201802180616/S201325141830021X/v1_201802180616/en/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S2013251418300208"
    "issn" => "20132514"
    "doi" => "10.1016/j.nefroe.2018.01.008"
    "estado" => "S300"
    "fechaPublicacion" => "2018-01-01"
    "aid" => "388"
    "documento" => "article"
    "crossmark" => 0
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia &#40;English Version&#41;. 2018;38:73-8"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 4404
      "formatos" => array:3 [
        "EPUB" => 274
        "HTML" => 3352
        "PDF" => 778
      ]
    ]
    "en" => array:12 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>"
      "titulo" => "Hyperuricemia is associated with progression of chronic kidney disease in patients with reduced functioning kidney mass"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "73"
          "paginaFinal" => "78"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Fig&#46; 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1663
              "Ancho" => 1632
              "Tamanyo" => 158415
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Relationship between hyperuricemia &#40;&#62;7<span class="elsevierStyleHsp" style=""></span>mg&#47;dl of uric acid level&#41; and renal disease progression &#40;Cox regression model&#41;&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Isabel Gal&#225;n, Marian Goicoechea, Borja Quiroga, Nicol&#225;s Mac&#237;as, Alba Santos, Maria Soledad Garc&#237;a de Vinuesa, &#218;rsula Verdalles, Santiago Cede&#241;o, Eduardo Verde, Ana P&#233;rez de Jos&#233;, Ana Garc&#237;a, Jos&#233; Lu&#241;o"
          "autores" => array:12 [
            0 => array:2 [
              "nombre" => "Isabel"
              "apellidos" => "Gal&#225;n"
            ]
            1 => array:2 [
              "nombre" => "Marian"
              "apellidos" => "Goicoechea"
            ]
            2 => array:2 [
              "nombre" => "Borja"
              "apellidos" => "Quiroga"
            ]
            3 => array:2 [
              "nombre" => "Nicol&#225;s"
              "apellidos" => "Mac&#237;as"
            ]
            4 => array:2 [
              "nombre" => "Alba"
              "apellidos" => "Santos"
            ]
            5 => array:2 [
              "nombre" => "Maria Soledad"
              "apellidos" => "Garc&#237;a de Vinuesa"
            ]
            6 => array:2 [
              "nombre" => "&#218;rsula"
              "apellidos" => "Verdalles"
            ]
            7 => array:2 [
              "nombre" => "Santiago"
              "apellidos" => "Cede&#241;o"
            ]
            8 => array:2 [
              "nombre" => "Eduardo"
              "apellidos" => "Verde"
            ]
            9 => array:2 [
              "nombre" => "Ana"
              "apellidos" => "P&#233;rez de Jos&#233;"
            ]
            10 => array:2 [
              "nombre" => "Ana"
              "apellidos" => "Garc&#237;a"
            ]
            11 => array:2 [
              "nombre" => "Jos&#233;"
              "apellidos" => "Lu&#241;o"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S021169951730108X"
        "doi" => "10.1016/j.nefro.2017.04.006"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S021169951730108X?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251418300208?idApp=UINPBA000064"
    "url" => "/20132514/0000003800000001/v1_201802180616/S2013251418300208/v1_201802180616/en/main.assets"
  ]
  "en" => array:20 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Short Original</span>"
    "titulo" => "Effects of rotigotine on clinical symptoms&#44; quality of life and sleep hygiene adequacy in hemodialysis-associated restless legs syndrome"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "79"
        "paginaFinal" => "86"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Vicent Esteve, Jose Carneiro, Gabriel Salazar, M&#243;nica Pou, Irati Tapia, Miquel Fulquet, Ver&#243;nica Duarte, Anna Saurina, F&#225;tima Moreno, Manel Ram&#237;rez de Arellano"
        "autores" => array:10 [
          0 => array:4 [
            "nombre" => "Vicent"
            "apellidos" => "Esteve"
            "email" => array:1 [
              0 => "vesteve&#64;cst&#46;cat"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:2 [
            "nombre" => "Jose"
            "apellidos" => "Carneiro"
          ]
          2 => array:2 [
            "nombre" => "Gabriel"
            "apellidos" => "Salazar"
          ]
          3 => array:2 [
            "nombre" => "M&#243;nica"
            "apellidos" => "Pou"
          ]
          4 => array:2 [
            "nombre" => "Irati"
            "apellidos" => "Tapia"
          ]
          5 => array:2 [
            "nombre" => "Miquel"
            "apellidos" => "Fulquet"
          ]
          6 => array:2 [
            "nombre" => "Ver&#243;nica"
            "apellidos" => "Duarte"
          ]
          7 => array:2 [
            "nombre" => "Anna"
            "apellidos" => "Saurina"
          ]
          8 => array:2 [
            "nombre" => "F&#225;tima"
            "apellidos" => "Moreno"
          ]
          9 => array:2 [
            "nombre" => "Manel"
            "apellidos" => "Ram&#237;rez de Arellano"
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Servei Nefrologia i Neurologia&#44; Hospital de Terrassa&#44; Consorci Sanitari Terrassa &#40;CST&#41;&#44; Barcelona&#44; Spain"
            "identificador" => "aff0005"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "<span class="elsevierStyleItalic">Corresponding author</span>&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Efectos de la rotigotina sobre la sintomatolog&#237;a&#44; calidad de vida e higiene de sue&#241;o en el s&#237;ndrome de piernas inquietas en hemodi&#225;lisis"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Fig&#46; 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 1061
            "Ancho" => 1677
            "Tamanyo" => 60891
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Causes of chronic kidney disease in patients with RLS in HD&#46; Results expressed in percentages &#40;&#37;&#41;&#46; DM&#58; diabetes mellitus&#59; AE Dis&#46;&#58; atheroembolic disease&#59; primary glomerular Dis&#58; primary glomerular disease&#59; HTN&#58; hypertension&#59; TI nephropathy&#58; tubulointerstitial nephropathy&#59; RLS&#58; restless legs syndrome&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Restless legs syndrome &#40;RLS&#41; is an entity characterized by an uncontrollable impulse to move limbs&#44; especially lower limbs&#44; accompanied by discomfort or unpleasant sensations in these extremities &#40;such as itching&#44; tingling&#44; pain&#44; stretching&#44; etc&#46;&#41;&#46; This occurs after a period of rest and are improved or disappear with movement&#46;<a class="elsevierStyleCrossRefs" href="#bib0130"><span class="elsevierStyleSup">1&#44;2</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">The diagnosis is based on the symptoms observed and the prevalence in the general population is between 5 and 10&#37;&#59; it is more frequent in women and in advanced ages&#46;<a class="elsevierStyleCrossRefs" href="#bib0140"><span class="elsevierStyleSup">3&#44;4</span></a> Patients with RLS have an impairement in the quality of life&#44; with clinical manifestations of depression or anxiety&#44; as well as a deterioration of sleep habits with daytime sleepiness and fatigue&#46; Some studies even point out a direct relationship between RLS and an increase in mortality&#46;<a class="elsevierStyleCrossRefs" href="#bib0150"><span class="elsevierStyleSup">5&#8211;7</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">The alterations of hypothalamic dopaminergic cells in response to elevated levels of some neurotransmitters&#44; the reduction of inhibition at the level of the motor cortex&#44; the hyperreactivity of the spinal flexor reflex or alterations of brain stem reflexes have been some of the diverse and complex neurological mechanisms involved in the pathophysiology of this syndrome&#46;<a class="elsevierStyleCrossRefs" href="#bib0165"><span class="elsevierStyleSup">8&#8211;10</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">From the etiological point of view&#44; there are two forms of RLS primary or idiopathic and the secondary&#46; The secondary forms are related to many etiologies&#44; although the most frequent are those associated with anemia with iron deficiency&#44; diabetic neuropathy&#44; neurodegenerative diseases &#8211; such as multiple sclerosis or Parkinson&#39;s disease &#8211; and the presence of advanced chronic kidney disease&#46;<a class="elsevierStyleCrossRefs" href="#bib0180"><span class="elsevierStyleSup">11&#8211;13</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">Uremia related RLS is often underdiagnosed&#46; Its prevalence is variable and it is estimated to be between 12 and 30&#37;&#46; The prevalence is higher among patients included in renal replacement therapy programs&#44; mainly in hemodialysis &#40;HD&#41;&#46;<a class="elsevierStyleCrossRefs" href="#bib0150"><span class="elsevierStyleSup">5&#44;14&#44;15</span></a> However&#44; there are not many published studies and they do not include many patients and in some cases with contradictory information&#46;</p><p id="par0030" class="elsevierStylePara elsevierViewall">Currently&#44; the pharmacological therapy of SPI is based mainly on the use of non-ergotamine dopamine agonists&#46;<a class="elsevierStyleCrossRefs" href="#bib0195"><span class="elsevierStyleSup">14&#44;15</span></a> Its main advantage&#44; compared to the classic use of levodopa and gabapentin&#44; lies mainly in the occurrence of fewer gastrointestinal adverse events&#46; The most commonly used are pramipexole&#44; ropinirole and&#44; more recently&#44; rotigotine&#46;<a class="elsevierStyleCrossRefs" href="#bib0205"><span class="elsevierStyleSup">16&#8211;18</span></a> Rotigotine shows a better control of symptoms&#44; less incidence of both adverse effects and paradoxical potentiation of symptoms &#40;augmentation effect&#41; as well as an ease administration and dosing to the HD patient&#46;<a class="elsevierStyleCrossRef" href="#bib0215"><span class="elsevierStyleSup">18</span></a></p><p id="par0035" class="elsevierStylePara elsevierViewall">Given the potential impact of the treatment of RLS on the quality of life and the medical implications&#44; together with the absence of reporto n national series&#44; we thought it would be interesting to conduct this study to describe the prevalence of RLS in our HD unit as well as analyzing the possible effects of rotigotine on the symptoms&#44; quality of life and sleep disorder in our HD patients with RLS&#46;</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Methods</span><p id="par0040" class="elsevierStylePara elsevierViewall">During the months from January to April 2015&#44; a prospective&#44; 12-week&#44; single-center study was performed in patients with RLS included in regular HD in our center&#46; The study was approved by the Hospital Ethics and Clinical Research Committee and it was carried out in accordance with the Helsinki Declaration&#46;</p><p id="par0045" class="elsevierStylePara elsevierViewall">The inclusion criteria were the following&#58; age equal to or greater than 18 years&#44; with the diagnosis of RLS and signing the informed consent&#46; The exclusion criteria were&#58; lack of informed consent and intellectually unable to answer the questionnaire&#46;</p><p id="par0050" class="elsevierStylePara elsevierViewall">The periodic HD program of our hospital distributes patients in 6 groups of 10&#8211;12 patients&#46; These groups perform sessions only in the high-flux HD modality with a 3&#46;5&#8211;4<span class="elsevierStyleHsp" style=""></span>h duration on alternate days &#40;L-X-V or M-J-S&#41;&#44; during morning&#44; noon &#40;3&#46;5<span class="elsevierStyleHsp" style=""></span>h&#41; and afternoon shifts&#46;</p><p id="par0055" class="elsevierStylePara elsevierViewall">There were two comparative study phases with a duration of six weeks each&#46; In the first phase &#40;phase 1&#41;&#44; HD patients at our center were diagnosed of RLS according to the international clinical criteria of the International Restless Leg Syndrome Study Group &#40;IRLSSG&#44; 2012&#41; 1&#46; All patients with RLS were evaluated by the same neurologist&#46; Patients who met 4 criteria were diagnosed of RLS&#46; In the second phase &#40;phase 2&#41;&#44; transdermal patches of rotigotine were administered during the first 2 weeks of the week &#40;1<span class="elsevierStyleHsp" style=""></span>mg&#47;day&#41; and in case of correct tolerance and absence of adverse effects&#44; the dose was increased daily up to 2<span class="elsevierStyleHsp" style=""></span>mg&#47;day&#46; After an individualized explanation of the administration system&#44; rotigotine transdermal patches were maintained for 24<span class="elsevierStyleHsp" style=""></span>h&#44; with rotation of the application sites&#46; In case of requiring dose reduction&#44; this was done progressively to avoid a rebound effect on symptomatology&#46;</p><p id="par0060" class="elsevierStylePara elsevierViewall">At the beginning of the study&#44; main demographic data were collected &#40;age&#44; gender&#44; ethiology of renal failure&#44; vintage&#41; and associated comorbidities &#40;diabetes mellitus&#44; arterial hypertension&#44; peripheral vascular disease&#44; ischemic heart disease&#44; Charlson comorbidity index&#44; smoking&#44; alcohol habit&#44; caffeine derivatives&#41;&#46; Both at the beginning and at the end of each of phases&#44; the main biochemical data were analyzed&#44; the patient&#39;s usual medication related to RLS&#44; as well as the characteristics and adequacy data in HD &#40;Kt&#47;V&#44; method 2nd generation Daugirdas&#41;&#46; Also&#44; the following variables were analyzed&#46;</p><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Degree of severity of restless legs syndrome symptoms and questionnaire on specific symptoms</span><p id="par0065" class="elsevierStylePara elsevierViewall">The degree of severity of the symptoms was determined by the severity scale &#40;GRLS&#41; established by the IRLSSG19 and the symptomatology in both lower limbs by means of a questionnaire of specific symptoms &#40;QS&#41;&#46; The GRLS is a validated survey in relation to the repercussion of the SPI symptomatology in each patient&#46; It consists of 10 questions with 5 possible answers&#46; Each answer is scored from 0 to 4&#46; The simplest way to analyze the result is the sum of the total score&#46; From 15 points up&#44; it is considered severe symptomatology&#46; The higher the score&#44; the greater the severity&#46; The QS assesses using a qualitative scale &#40;1&#58; null&#44; 2&#8211;3&#58; little 4&#58; enough&#44; 5&#58; a lot&#41; the presence of the following symptoms&#58; muscle pain&#44; cramps&#44; tingling&#44; burning and numbness&#46;</p><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Quality of life and sleep habits</span><p id="par0070" class="elsevierStylePara elsevierViewall">Quality of life was assessed using an approved health questionnaire adapted to RLS&#58; John Hopkins RLS QoL &#40;JH-QoL&#41;&#46;<a class="elsevierStyleCrossRef" href="#bib0225"><span class="elsevierStyleSup">20</span></a> Includes 18 questions with 5 possible answers and a score from 0 to 4&#46; The simplest way to analyze the results is the sum of the total score&#46; Overall&#44; the higher the score&#44; the poorer quality of life for a RLS patient&#46; The sleep habit was evaluated using the validated SCOPA<a class="elsevierStyleCrossRef" href="#bib0230"><span class="elsevierStyleSup">21</span></a> survey&#46; It consists of 2 sections&#59; the first evaluates the nighttime sleep&#46; It consists of 6 questions&#44; 5 more specific and valued from 0 &#40;not&#41; to 3 &#40;much&#41; and a sixth question that is dedicated to global assessment with 7 possibilities from 0 &#40;very bad&#41; to 7 &#40;very good&#41;&#46; In the second section daytime sleepiness is assessed&#46; It consists of 6 specific questions valued from 0 &#40;never&#41; to 3 &#40;frequently&#41;&#46; The global analysis is done by the sum of points in each section &#40;nocturnal sleep&#47;daytime sleepiness&#41;&#46;</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Efficacy of the treatment&#44; therapeutic completion and adverse effects</span><p id="par0075" class="elsevierStylePara elsevierViewall">With regard to the effectiveness of the treatment&#44; a partial response was defined as a reduction of more than 20&#37; in the QS&#46; A complete response was defined as a reduction of more than 80&#37; in the QS and the presence of &#8220;zero&#8221; symptoms was defined by a score lower than 5 points in the QS&#46;</p><p id="par0080" class="elsevierStylePara elsevierViewall">Compliance with the treatment was evaluated by reviewing the transdermal patch at the beginning of the HD session&#46; Those patients who presented absence of the transdermal patch in 3 regular revisions were classified as noncompliant&#46;</p><p id="par0085" class="elsevierStylePara elsevierViewall">Adverse effects analyzed by anamnesis during the usual sessions of HD were&#58; allergic-type reactions in the area of application &#40;erythema or induration&#44; local pain&#44; pruritus&#41;&#44; headache&#44; drowsiness&#44; nausea&#44; vomiting&#44; dyspepsia&#44; hypertension and paradoxical potentiation of the symptoms &#40;augmentation effect&#41;&#46;</p><p id="par0090" class="elsevierStylePara elsevierViewall">The statistical analysis was performed using the SPSS program version 18&#46;0 &#40;SPSS Inc&#44; Chicago&#44; IL&#44; USA&#41;&#46; By Kolmogorov&#8211;Smirnov test the data did not present a normal distribution&#46; The quantitative variables were expressed by means and standard deviation&#46; The qualitative variables&#44; by percentage&#46; The quantitative data were compared using the Wilcoxon test for nonparametric related variables and the qualitative data using the McNemar test&#46; The intergroup analysis was carried out using the Mann&#8211;Whitney <span class="elsevierStyleItalic">U</span> test&#44; considering a <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;05 value as statistical significance&#46;</p></span></span></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Results</span><p id="par0095" class="elsevierStylePara elsevierViewall">A total of 66 patients prevalent in the HD program were analyzed&#46; Five were excluded &#40;3 had dementia&#44; one did not accept to participate and another patient had a psychiatric disorder&#41;&#46; Of the remaining 61 patients&#44; 14 were diagnosed with RLS&#44; with a prevalence of 22&#46;9&#37;&#46; During the study period there were 5 dropouts &#40;one due to cardiorespiratory arrest&#44; 3 due to revocation of informed consent and one due to malignant hematological disease&#41;&#44; none of dropouts was the related to the present study&#46; Of the 9 remaining patients&#44; 44&#46;4&#37; were men&#44; with an average age of 70&#46;2 years<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>9&#46;9 years and a mean time on HD of 111&#46;1<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>160&#46;8 months&#46; The average Charlson index was 10&#46;2<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>2&#46; The main comorbidities were&#58; arterial hypertension &#40;88&#46;9&#37;&#41;&#44; diabetes mellitus &#40;77&#46;8&#37;&#41;&#44; peripheral vascular disease &#40;55&#46;6&#37;&#41; and ischemic heart disease &#40;22&#46;2&#37;&#41;&#46; The main etiology of chronic kidney disease was diabetes mellitus &#40;44&#46;4&#37;&#41;&#46; The rest of the etiologies are shown in <a class="elsevierStyleCrossRef" href="#fig0005">Fig&#46; 1</a>&#46; Among the potential triggers&#44; 44&#46;4&#37; consumed caffeine derivatives on a regular basis&#44; 25&#37; had alcohol consumption and 35&#46;7&#37; had active smoking&#46;</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0100" class="elsevierStylePara elsevierViewall">No significant differences were observed in the main biochemical parameters and HD adequacy in both phases of the study &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#41;&#46; Similarly&#44; no changes were made in the patient&#39;s usual medication related to RLS during the study &#40;88&#46;9&#37; conventional analgesia&#44; 33&#46;3&#37; antidepressants or anxiolytics and 11&#46;1&#37; took opioids&#44; respectively&#41;&#46; No patient was taking levodopa&#44; clonidine&#44; gabapentin&#44; <span class="elsevierStyleSmallCaps">l</span>-carnitine or antiemetics&#46; The characteristics of the HD filter were maintained &#40;helixone 33&#37;&#44; polysulfone 44&#37;&#44; polysulfone hi-flow 11&#37;&#44; polyacrylonitrile 11&#37;&#41; and no relevant changes were observed in the usual treatment given during HD sessions throughout the study &#40;iron intravenous 77&#46;8 vs&#46; 72&#46;5&#37;&#44; erythropoietic agents 30&#46;9<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>11&#46;6 vs&#46; 28&#46;8<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>10&#46;4<span class="elsevierStyleHsp" style=""></span>mcg darbopoetin&#47;week&#41;&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0105" class="elsevierStylePara elsevierViewall">The values of the main variables analyzed in the different phases of the study are shown in <a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>&#46; Regarding the severity of the symptoms&#44; 73&#46;3&#37; had severe symptoms &#40;GRLS<span class="elsevierStyleHsp" style=""></span>&#62;<span class="elsevierStyleHsp" style=""></span>P15&#41;&#44; 35&#46;7&#37; reported cramping&#44; 28&#46;5&#37; numbness and 21&#46;4&#37; muscle pain and burning&#44; in the QS of the lower extremities&#46; No relevant changes were observed in the GRLS scale &#40;19&#46;1<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>9&#46;2 vs&#46; 21&#46;1<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>4&#46;2&#44; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;524&#41; or in the QS questionnaire &#40;9&#46;3<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1&#46;7 vs 10&#46;2<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>2&#46;4&#59; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;428&#41; during phase 1 of the study&#46;</p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia><p id="par0110" class="elsevierStylePara elsevierViewall">During phase 2 of the study&#44; we observed a significant improvement in GRLS &#40;21&#46;1<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>43 vs&#46; 5&#46;7<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>4&#46;6&#59; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;001&#41; and QS &#40;10&#46;2<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>2&#46;4 vs&#46; 5&#46;7<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1&#46;1&#59; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#62;<span class="elsevierStyleHsp" style=""></span>0&#46;004&#41; after the introduction of rotigotine treatment&#46; The dose of transdermal rotigotine administered was 2<span class="elsevierStyleHsp" style=""></span>mg&#47;day&#44; with complete therapeutic compliance&#46; A 88&#46;8&#37; of the patients responded to the treatment with rotigotine&#44; with an average reduction of 15&#46;2<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>17&#46;2 points in the GRLS scale at the end of phase 2 of the study&#46; A 77&#46;7&#37; presented a partial response &#40;reduction greater than 20&#37; QS&#41; and 11&#46;1&#37; presented a complete remission &#40;reduction greater than 80&#37; in QS&#41;&#46; A 55&#46;5&#37; reached &#8220;zero&#8221; symptoms&#44; defined by a score lower than 5 points in the QS&#46; No allergic reactions were observed in the application area&#46; Only one patient presented mild gastro intestinal intolerance in the form of dyspepsia&#44; which yielded after the reduction of rotigotine to 1<span class="elsevierStyleHsp" style=""></span>mg&#47;day&#46; None of the patients in our study presented augmentation effect&#46;</p><p id="par0115" class="elsevierStylePara elsevierViewall">As far as quality of life related to RLS and sleep habits&#44; we observed a worsening for the JH-QoL scales &#40;19&#46;8<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>43 vs&#46; 22&#46;1<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>4&#46;4&#59; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;096&#41; and SCOPA &#40;total 15&#46;1<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>5&#46;3 vs&#46; 16<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>5&#46;3&#44; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;124&#59; diurnal&#44; 5&#46;3<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>3&#46;6 vs&#46; 5&#46;5<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>3&#46;6&#44; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;368&#59; nocturnal 9&#46;8<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>2&#46;7 vs&#46; 10&#46;4<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>2&#46;7&#59; <span class="elsevierStyleItalic">p</span> 0&#46;347&#41; during phase 1 of the study&#44; although these results did not reach statistical significance&#46; Overall&#44; after the introduction of rotigotine &#40;phase 2&#41;&#44; we observed a significant improvement in terms of quality of life related to SPI &#40;JH-QoL 22&#46;1<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>4&#46;4 vs&#46; 4&#46;3<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>4&#46;1&#59; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;004&#41; and in the different sections of sleep habits &#40;total SCOPA 16<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>5&#46;3 vs&#46; 6&#46;7<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1&#46;9&#59; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;001&#59; diurnal 5&#46;5<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>3&#46;6 vs&#46; 1&#46;4<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>0&#46;7&#59; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;013&#59; nocturnal 10&#46;4<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>2&#46;7 vs&#46; 6&#46;1<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1&#46;1&#59; <span class="elsevierStyleItalic">p</span> 0&#46;001&#41;&#46;</p><p id="par0120" class="elsevierStylePara elsevierViewall"><a class="elsevierStyleCrossRef" href="#tbl0015">Table 3</a> shows the difference of means of the main variables in the different phases of the study&#46; There was a significant improvement in terms of severity of symptoms &#40;1&#46;8<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>8&#46;5 vs&#46; &#8722;13&#46;3<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>8&#46;7&#59; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;003&#41;&#44; presence of specific symptoms in the lower extremities &#40;0&#46;6<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>2&#46;4 vs&#46; &#8722;4&#46;2<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>3&#46;1&#59; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;004&#41;&#44; quality of life related to RLS &#40;2&#46;3<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1&#46;6 vs&#46; &#8722;12&#46;7<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>3&#46;8&#59; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;001&#41; and sleep habits &#40;total 0&#46;9<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1&#46;1 vs&#46; &#8722;9&#46;2<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>5&#46;3&#59; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;001&#59; diurnal 0&#46;2<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>0&#46;6 vs 4&#46;1<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>3&#46;9&#44; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;001&#44; nocturnal 0&#46;6<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>0&#46;7 vs&#46; &#8722;4&#46;4<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>2&#46;3&#44; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;001&#41;&#44; after the introduction of rotigotine&#46;</p><elsevierMultimedia ident="tbl0015"></elsevierMultimedia></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Discussion</span><p id="par0125" class="elsevierStylePara elsevierViewall">The results of our study show that the RLS is frequent in our HD unit&#46; In these patients&#44; the use of rotigotine improved the clinical symptoms&#44; quality of life and sleep habits&#59; it is a safe drug&#44; with minimal adverse effects and complete therapeutic compliance&#46;</p><p id="par0130" class="elsevierStylePara elsevierViewall">The prevalence of RLS in our HD unit&#44; it is practically the same as previously described in the literature<a class="elsevierStyleCrossRefs" href="#bib0145"><span class="elsevierStyleSup">4&#44;22</span></a>&#58; it ranges from 12 and 30&#37;&#44; despite the high comorbidity and prolonged time on HD&#46; Patients with RLS have a decreased in life quality with depression and anxiety as well as a abnormalities in sleep habits producing daytime sleepiness and fatigue&#46;<a class="elsevierStyleCrossRefs" href="#bib0150"><span class="elsevierStyleSup">5&#44;19&#44;20</span></a> These data are similar to those observed in our study&#44; in which more than 75&#46;5&#37; of patients had severe symptoms&#46; The presence of all these symptoms affected quality of life and sleep habits&#46;</p><p id="par0135" class="elsevierStylePara elsevierViewall">Currently&#44; therapy with non-ergotamine dopamine agonists has become the first-line of therapy for moderate-severe involvement of RLS&#46; The most commonly used medications are pramipexole&#44; ropinirole and&#44; more recently&#44; rotigotine&#46;<a class="elsevierStyleCrossRefs" href="#bib0200"><span class="elsevierStyleSup">15&#8211;17</span></a> However&#44; there are still few published work evaluating the best treatment of RLS in HD patients<a class="elsevierStyleCrossRef" href="#bib0240"><span class="elsevierStyleSup">23</span></a> &#40;<a class="elsevierStyleCrossRef" href="#tbl0020">Table 4</a>&#41;&#46;</p><elsevierMultimedia ident="tbl0020"></elsevierMultimedia><p id="par0140" class="elsevierStylePara elsevierViewall">Within this group of drugs&#44; the use of rotigotine has been extended in the every day practice due to the efficacy&#44; good tolerance&#44; few adverse effects&#44; low prevalence of paradoxical potentiation of symptoms or augmentation effect and no need for dose adjustment in CKD patients&#46;<a class="elsevierStyleCrossRefs" href="#bib0245"><span class="elsevierStyleSup">24&#44;25</span></a> These advantages are mainly due to the administration in the form of transdermal patch&#44; which guarantees a continuous delivery throughout the day achieving stable serum levels that minimize the possibility of accumulation and there is no need to monitor blood levels and adverse effects are uncommon&#46; In addition transdermal application facilitates therapeutic adherence&#44; by decreasing the number of tablets the majority of patients on multiple medications&#44; facilitating therapeutic compliance&#46; The draw back is the high cost&#44; superior to the rest of the non-ergotamine agonists&#46; In our study&#44; rotigotine was a safe and effective drug&#44; with minimal adverse effects and complete therapeutic compliance&#44; there were no dropouts and achieved a significant improvement in clinical symptoms&#44; quality of life related to RLS and sleep habits&#46;</p><p id="par0145" class="elsevierStylePara elsevierViewall">To date&#44; uremic RLS has been underestimated as evidenced by the fact that none of the patients diagnosed received specific treatment for RLS&#46; Among other reasons&#44; this was probably due to&#58; the fact that symptoms in the lower limbs could be attributed to other factors or associated comorbidities&#44; the scant interest by the medical staff due in part to the lack of physiopathological knowledge of this entity and the absence of an effective treatment free of relevant adverse effects&#46; All these aspects have lead to the use of various medications without clear guidelines&#44; based on the clinical experiences themselves or on a few published works&#46;</p><p id="par0150" class="elsevierStylePara elsevierViewall">There is a significant prevalence of RLS&#44; a pathology that causes significant symptomatology associated to deterioration of the quality of life&#44; without lack of specific abnormalities in blood count or biochemical parameters&#46; Based on the results obtained in this study we should consider establishing different strategies to assess the presence of RLS in our patients&#46;</p><p id="par0155" class="elsevierStylePara elsevierViewall">In this sense&#44; all the incident patients in our HD unit will be evaluated for RLS according to the clinical criteria of the IRLSSG&#46; Those cases with reasonable doubts will be discussed with the Neurology Service for a more exhaustive assessment&#46; In the same way&#44; the severity of the symptoms and the quality of life and sleep habits will be assessed by means of the tests described above and&#44; in addition the patient will receive dietetic advice and the appropriate medical treatment according to the individual clinical characteristics&#46;</p><p id="par0160" class="elsevierStylePara elsevierViewall">Within the multiple limitations of our study&#44; we must mention the small number of patients included which forced the use of nonparametric statistical tests&#44; as well as the short time of follow-up&#46; The sample size was conditioned by our limited population in HD&#44; while the 12-week period was established to avoid possible confounding effect derived from the usual changes in medications after the quarterly analytical determinations in our HD unit&#46; Therefore&#44; we cannot rule out the possibility that a longer period of followup could entail some change in relation to the effectiveness&#44; safety and tolerance of rotigotine&#46; Studies with a larger number of patients and longer duration would be necessary to confirm the benefits of rotigotine observed in our patients in HD&#46;</p><p id="par0165" class="elsevierStylePara elsevierViewall">In conclusion&#44; we can state that there is considerable prevalence RLS&#44; with an intense symptomatology and a deteriorated quality of life and sleep habits&#46; The use of rotigotine improved clinical symptoms&#44; quality of life and sleep habits in HD patients with RLS&#46; It proved to be a safe drug&#44; with minimal adverse effects and complete therapeutic compliance&#46; However&#44; future studies would be necessary to confirm the benefit of rotigotine in the HD population with RLS&#46;</p></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Conflicts of interest</span><p id="par0170" class="elsevierStylePara elsevierViewall">The authors declare that they have no conflicts of interest&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:10 [
        0 => array:3 [
          "identificador" => "xres985608"
          "titulo" => "Abstract"
          "secciones" => array:5 [
            0 => array:2 [
              "identificador" => "abst0005"
              "titulo" => "Background"
            ]
            1 => array:2 [
              "identificador" => "abst0010"
              "titulo" => "Objectives"
            ]
            2 => array:2 [
              "identificador" => "abst0015"
              "titulo" => "Material and methods"
            ]
            3 => array:2 [
              "identificador" => "abst0020"
              "titulo" => "Results"
            ]
            4 => array:2 [
              "identificador" => "abst0025"
              "titulo" => "Conclusions"
            ]
          ]
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec953256"
          "titulo" => "Keywords"
        ]
        2 => array:3 [
          "identificador" => "xres985607"
          "titulo" => "Resumen"
          "secciones" => array:5 [
            0 => array:2 [
              "identificador" => "abst0030"
              "titulo" => "Introducci&#243;n"
            ]
            1 => array:2 [
              "identificador" => "abst0035"
              "titulo" => "Objetivos"
            ]
            2 => array:2 [
              "identificador" => "abst0040"
              "titulo" => "Material y m&#233;todos"
            ]
            3 => array:2 [
              "identificador" => "abst0045"
              "titulo" => "Resultados"
            ]
            4 => array:2 [
              "identificador" => "abst0050"
              "titulo" => "Conclusiones"
            ]
          ]
        ]
        3 => array:2 [
          "identificador" => "xpalclavsec953255"
          "titulo" => "Palabras clave"
        ]
        4 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Introduction"
        ]
        5 => array:3 [
          "identificador" => "sec0010"
          "titulo" => "Methods"
          "secciones" => array:1 [
            0 => array:3 [
              "identificador" => "sec0015"
              "titulo" => "Degree of severity of restless legs syndrome symptoms and questionnaire on specific symptoms"
              "secciones" => array:2 [
                0 => array:2 [
                  "identificador" => "sec0020"
                  "titulo" => "Quality of life and sleep habits"
                ]
                1 => array:2 [
                  "identificador" => "sec0025"
                  "titulo" => "Efficacy of the treatment&#44; therapeutic completion and adverse effects"
                ]
              ]
            ]
          ]
        ]
        6 => array:2 [
          "identificador" => "sec0030"
          "titulo" => "Results"
        ]
        7 => array:2 [
          "identificador" => "sec0035"
          "titulo" => "Discussion"
        ]
        8 => array:2 [
          "identificador" => "sec0040"
          "titulo" => "Conflicts of interest"
        ]
        9 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2016-10-03"
    "fechaAceptado" => "2017-03-16"
    "PalabrasClave" => array:2 [
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec953256"
          "palabras" => array:3 [
            0 => "Restless legs syndrome"
            1 => "Hemodialysis"
            2 => "Rotigotine"
          ]
        ]
      ]
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec953255"
          "palabras" => array:3 [
            0 => "S&#237;ndrome de piernas inquietas"
            1 => "Hemodi&#225;lisis"
            2 => "Rotigotina"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "en" => array:3 [
        "titulo" => "Abstract"
        "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Background</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Restless legs syndrome &#40;RLS&#41; is a neurological disorder characterized by bothersome symptoms associated with impaired quality of life and sleep hygiene&#46; Rotigotine is a novel therapeutic alternative&#44; although few studies have been published in patients on hemodialysis &#40;HD&#41; with RLS treated with rotigotine&#46;</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Objectives</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">&#40;1&#41; To establish the prevalence of RLS in our HD unit&#46; &#40;2&#41; To evaluate the efficacy and safety profile of rotigotine and its effect on symptoms&#44; quality of life and sleep hygiene in our HD population with RLS&#46;</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Material and methods</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">A single-center&#44; 12-week prospective study&#46; Two stages &#40;6 weeks&#41;&#58; stage 1 &#40;no treatment&#41; and stage 2 &#40;rotigotine&#41;&#46; We analyzed&#58; &#40;1&#41; Demographic data&#44; biochemistry data&#44; HD suitability parameters and RLS medical treatment data&#46; &#40;2&#41; Lower extremity symptoms questionnaire &#40;QS&#41;&#46; &#40;3&#41; RLS severity symptoms scale &#40;SRLSS&#41;&#46; &#40;4&#41; RLS quality of life&#58; John Hopkins RLS-QoL &#40;JH-QoL&#41;&#46; &#40;5&#41; Sleep hygiene&#58; SCOPA Scale&#46;</p></span> <span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Results</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">We included 66 HD patients&#44; 14 with RLS&#59; 44&#46;4&#37; male&#44; 70&#46;2<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>9&#46;9 years and 111&#46;1<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>160&#46;8 months on HD and 22&#46;9&#37; RLS&#46; Exclusively in stage 2&#44; a significant improvement for QS &#40;10<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>2&#46;4 vs&#46; 5&#46;7<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1&#46;0&#41;&#44; SRLSS &#40;21<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>4 vs&#46; 5&#46;7<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>4&#46;6&#41;&#44; JH-QoL &#40;22&#46;1<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>4&#46;4 vs&#46; 4&#46;3<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>4&#46;0&#41; and SCOPA &#40;16<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>5&#46;3 vs&#46; 6&#46;7<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1&#46;9&#41; were observed&#46; A 77&#46;7 and 11&#46;1&#37;&#44; showed partial &#40;&#62;20&#37;&#41; and complete &#40;&#62;80&#37;&#41; remission&#44; respectively&#44; while 55&#46;5&#37; achieved &#8220;zero&#8221; symptoms&#46; Only one patient had gastrointestinal intolerance and none experienced augmentation effect&#46; No changes in biochemical data&#44; suitability for dialysis or medical treatment were found&#46; The inter-group analysis showed a significant improvement in relation to QS&#44; SRLSS&#44; JH-QoL and SCOPA in stage 2&#46;</p></span> <span id="abst0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Conclusions</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">RLS showed a considerable prevalence in our HD unit&#46; Rotigotine improved clinical symptoms&#44; quality of life and sleep hygiene in RLS patients on HD and was found to be a safe drug with minimal side effects and total therapeutic compliance&#46; Nevertheless&#44; future studies should be performed to confirm the benefits of rotigotine in RLS patients on hemodialysis&#46;</p></span>"
        "secciones" => array:5 [
          0 => array:2 [
            "identificador" => "abst0005"
            "titulo" => "Background"
          ]
          1 => array:2 [
            "identificador" => "abst0010"
            "titulo" => "Objectives"
          ]
          2 => array:2 [
            "identificador" => "abst0015"
            "titulo" => "Material and methods"
          ]
          3 => array:2 [
            "identificador" => "abst0020"
            "titulo" => "Results"
          ]
          4 => array:2 [
            "identificador" => "abst0025"
            "titulo" => "Conclusions"
          ]
        ]
      ]
      "es" => array:3 [
        "titulo" => "Resumen"
        "resumen" => "<span id="abst0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Introducci&#243;n</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">El s&#237;ndrome de piernas inquietas &#40;SPI&#41; es un trastorno neurol&#243;gico caracterizado por una molesta sintomatolog&#237;a&#44; asociado a deterioro de calidad de vida e higiene de sue&#241;o&#46; Rotigotina constituye una novedosa alternativa terap&#233;utica&#44; si bien existen escasos estudios publicados sobre rotigotina en pacientes en hemodi&#225;lisis &#40;HD&#41; con SPI&#46;</p></span> <span id="abst0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Objetivos</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">1&#46;- Establecer la prevalencia de SPI en nuestra unidad de HD&#46; 2&#46;- Evaluar la eficacia y el perfil de seguridad asociado a rotigotina as&#237; como su efecto sobre la sintomatolog&#237;a&#44; calidad de vida e higiene del sue&#241;o en nuestra poblaci&#243;n en HD con SPI&#46;</p></span> <span id="abst0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Material y m&#233;todos</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">Estudio unic&#233;ntrico&#44; prospectivo de 12 semanas de duraci&#243;n&#46; Dos fases &#40;6 semanas&#41;&#58; fase 1 &#40;no tratamiento&#41; y fase 2 &#40;rotigotina&#41;&#46; Analizamos&#58; 1&#46;- Datos demogr&#225;ficos&#44; bioqu&#237;micos&#44; par&#225;metros de adecuaci&#243;n de HD y tratamiento m&#233;dico relacionado con SPI&#46; 2&#46;- Cuestionario sobre s&#237;ntomas en extremidades inferiores &#40;QS&#41;&#46; 3&#46;- Escala de gravedad de los s&#237;ntomas &#40;GRLS&#41;&#46; 4&#46;- Calidad de vida SPI&#58; John Hopkins RLS-QoL &#40;JH-QoL&#41;&#46; 5&#46;- Higiene del sue&#241;o&#58; Escala SCOPA&#46;</p></span> <span id="abst0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Resultados</span><p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Se incluy&#243; a 66 pacientes en HD&#46; De ellos&#44; 14 con SPI&#59; el 44&#44;4&#37; eran hombres&#44; con 70&#44;2<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>9&#44;9 a&#241;os y 111&#44;1<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>160&#44;8 meses en HD&#46; El 22&#44;9&#37;&#44; con SPI&#46; &#218;nicamente en la fase 2 observamos una mejor&#237;a significativa para QS &#40;10<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>2&#44;4 vs&#46; 5&#44;7<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1&#44;0&#41;&#44; GRLS &#40;21<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>4 vs&#46; 5&#44;7<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>4&#44;6&#41;&#44; JH-QoL &#40;22&#44;1<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>4&#44;4 vs&#46; 4&#44;3<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>4&#44;0&#41; y SCOPA &#40;16<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>5&#44;3 vs&#46; 6&#44;7<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1&#44;9&#41;&#46; Un 77&#44;7 y un 11&#44;1&#37; presentaron remisi&#243;n parcial &#40;&#62;20&#37;&#41; y completa &#40;&#62;80&#37;&#41;&#44; respectivamente&#46; Un 55&#44;5&#37; alcanz&#243; sintomatolog&#237;a &#171;cero&#187;&#46; Un &#250;nico paciente present&#243; intolerancia digestiva y ninguno&#44; <span class="elsevierStyleItalic">augmentation efect</span>&#46; No observamos cambios en datos bioqu&#237;micos&#44; adecuaci&#243;n dial&#237;tica ni tratamiento m&#233;dico&#46; El an&#225;lisis intergrupos mostr&#243; una mejor&#237;a significativa en la fase 2 con relaci&#243;n a QS&#44; GRLSS&#44; JH-QoL y SCOPA&#46;</p></span> <span id="abst0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Conclusiones</span><p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">En nuestro estudio&#44; el SPI ur&#233;mico present&#243; una prevalencia considerable&#46; Rotigotina mejor&#243; la sintomatolog&#237;a cl&#237;nica&#44; la calidad de vida y la higiene de sue&#241;o en los pacientes con SPI en HD&#44; por lo que resulta ser un f&#225;rmaco seguro&#44; con m&#237;nimos efectos adversos y con cumplimento terap&#233;utico completo&#46; No obstante&#44; ser&#237;an necesarios futuros estudios para confirmar el beneficio de rotigotina en la poblaci&#243;n en HD con SPI&#46;</p></span>"
        "secciones" => array:5 [
          0 => array:2 [
            "identificador" => "abst0030"
            "titulo" => "Introducci&#243;n"
          ]
          1 => array:2 [
            "identificador" => "abst0035"
            "titulo" => "Objetivos"
          ]
          2 => array:2 [
            "identificador" => "abst0040"
            "titulo" => "Material y m&#233;todos"
          ]
          3 => array:2 [
            "identificador" => "abst0045"
            "titulo" => "Resultados"
          ]
          4 => array:2 [
            "identificador" => "abst0050"
            "titulo" => "Conclusiones"
          ]
        ]
      ]
    ]
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0015">Please cite this article as&#58; Esteve V&#44; Carneiro J&#44; Salazar G&#44; Pou M&#44; Tapia I&#44; Fulquet M&#44; et al&#46; Efectos de la rotigotina sobre la sintomatolog&#237;a&#44; calidad de vida e higiene de sue&#241;o en el s&#237;ndrome de piernas inquietas en hemodi&#225;lisis&#46; Nefrologia&#46; 2018&#59;38&#58;79&#8211;86&#46;</p>"
      ]
    ]
    "multimedia" => array:5 [
      0 => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Fig&#46; 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 1061
            "Ancho" => 1677
            "Tamanyo" => 60891
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Causes of chronic kidney disease in patients with RLS in HD&#46; Results expressed in percentages &#40;&#37;&#41;&#46; DM&#58; diabetes mellitus&#59; AE Dis&#46;&#58; atheroembolic disease&#59; primary glomerular Dis&#58; primary glomerular disease&#59; HTN&#58; hypertension&#59; TI nephropathy&#58; tubulointerstitial nephropathy&#59; RLS&#58; restless legs syndrome&#46;</p>"
        ]
      ]
      1 => array:8 [
        "identificador" => "tbl0005"
        "etiqueta" => "Table 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at1"
            "detalle" => "Table "
            "rol" => "short"
          ]
        ]
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">Phase 1 and phase 2 &#40;rotigotine 2<span class="elsevierStyleHsp" style=""></span>mg&#47;day&#41;&#58; results are expressed as mean &#40;standard deviation&#41;&#44; initial vs&#46; final&#46;</p><p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">Ca&#58; calcium&#59; Hs-CRP&#58; C-reactive protein&#59; i-PTH&#58; intact parathyroid hormone&#59; K&#58; potassium&#59; Kt&#47;V&#58; 2nd generation method Daurgirdas&#59; Mg&#58; magnesium&#59; P&#58; phosphorus&#59; VitD&#58; vitamin D&#46;</p><p id="spar0075" class="elsevierStyleSimplePara elsevierViewall">No significant differences were found between the groups studied&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="" valign="top" scope="col">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " colspan="2" align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Phase 1</th><th class="td" title="table-head  " colspan="2" align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Phase 2</th></tr><tr title="table-row"><th class="td" title="table-head  " align="" valign="top" scope="col" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Initial&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Final&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Initial&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Final&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry  " colspan="5" align="left" valign="top"><span class="elsevierStyleItalic">Biochemical data</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Urea&#44; mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">237&#46;2 &#40;80&#46;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">234&#46;7 &#40;85&#46;4&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">236&#46;6 &#40;85&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">238&#46;1 &#40;87&#46;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Glucose&#44; mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">153&#46;2 &#40;51&#46;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">155&#46;8 &#40;62&#46;4&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">152&#46;2 &#40;32&#46;1&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">155&#46;4 &#40;36&#46;1&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Creatinine&#44; mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">8&#46;1 &#40;2&#46;3&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">8&#46;2 &#40;3&#46;1&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">8&#46;2 &#40;2&#46;3&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">8&#46;1 &#40;2&#46;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>K&#44; mEq&#47;L&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">5&#46;2 &#40;0&#46;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">5&#46;5 &#40;1&#46;1&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">5&#46;1 &#40;0&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">5&#46;2 &#40;0&#46;7&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Ca&#44; mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">9&#46;2 &#40;0&#46;4&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">9&#46;2 &#40;0&#46;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">9&#46;2 &#40;0&#46;4&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">9&#46;3 &#40;0&#46;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>P&#44; mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">4&#46;4 &#40;1&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">4&#46;3 &#40;1&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">4&#46;4 &#40;1&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">4&#46;3 &#40;1&#46;1&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Mg&#44; mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1&#46;9 &#40;0&#46;9&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1&#46;9 &#40;0&#46;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1&#46;8 &#40;0&#46;7&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1&#46;9 &#40;0&#46;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>i-PTH&#44; pg&#47;ml&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">257&#46;6 &#40;189&#46;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">265&#46;8 &#40;196&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">264&#46;4 &#40;110&#46;7&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">258&#46;4 &#40;183&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>25-OH vitD&#44; ng&#47;ml&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">23&#46;3 &#40;8&#46;1&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">26&#46;7 &#40;11&#46;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">28&#46;2 &#40;13&#46;5&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">27&#46;1 &#40;7&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Albumin&#44; g&#47;dL&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">3&#46;7 &#40;0&#46;3&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">3&#46;7 &#40;0&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">3&#46;8 &#40;0&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">3&#46;7 &#40;0&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Prealbumin&#44; mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">28&#46;5 &#40;10&#46;5&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">28&#46;1 &#40;4&#46;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">29&#46;2 &#40;6&#46;7&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">29&#46;7 &#40;7&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Total cholesterol&#44; mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">143&#46;2 &#40;57&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">148&#46;1 &#40;59&#46;1&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">153&#46;2 &#40;34&#46;4&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">149&#46;9 &#40;34&#46;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>HDL cholesterol&#44; mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">42&#46;6 &#40;11&#46;1&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">41&#46;2 &#40;11&#46;9&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">42&#46;7 &#40;10&#46;3&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">41&#46;2 &#40;43&#46;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>LDL cholesterol&#44; mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">68&#46;7 &#40;42&#46;3&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">63&#46;4 &#40;49&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">67&#46;2 &#40;65&#46;4&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">65&#46;9 &#40;33&#46;7&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Triglycerides&#44; mg&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">156&#46;1 &#40;74&#46;1&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">158&#46;6 &#40;72&#46;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">157&#46;2 &#40;70&#46;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">157&#46;2 &#40;71&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="5" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="5" align="left" valign="top"><span class="elsevierStyleItalic">Hemogram</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Hemoglobin&#44; g&#47;dl&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">10&#46;8 &#40;1&#46;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">11&#46;1 &#40;0&#46;9&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">10&#46;5 &#40;1&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">10&#46;9 &#40;0&#46;7&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Ferritin&#44; ng&#47;ml&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">411&#46;6 &#40;210&#46;7&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">427&#46;2 &#40;267&#46;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">424&#46;1 &#40;204&#46;9&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">421&#46;9 &#40;300&#46;1&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Hs-CRP&#44; ng&#47;L&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">7&#46;8 &#40;1&#46;5&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">8&#46;1 &#40;1&#46;7&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">8&#46;1 &#40;1&#46;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">8&#46;3 &#40;1&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="5" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="5" align="left" valign="top"><span class="elsevierStyleItalic">Dialysis adequacy</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Weekly hours of HD&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">11&#46;1 &#40;0&#46;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">11&#46;1 &#40;0&#46;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">11&#46;1 &#40;0&#46;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">11&#46;1 &#40;0&#46;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Dose of dialysis&#44; Kt&#47;V&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1&#46;62 &#40;0&#46;4&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1&#46;63 &#40;0&#46;7&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1&#46;63 &#40;0&#46;5&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1&#46;62 &#40;0&#46;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1672130.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">Biochemical parameters and adequacy of hemodialysis&#46;</p>"
        ]
      ]
      2 => array:8 [
        "identificador" => "tbl0010"
        "etiqueta" => "Table 2"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at2"
            "detalle" => "Table "
            "rol" => "short"
          ]
        ]
        "tabla" => array:3 [
          "leyenda" => "<p id="spar0085" class="elsevierStyleSimplePara elsevierViewall">Phase 1 and phase 2 &#40;rotigotine 2<span class="elsevierStyleHsp" style=""></span>mg&#47;day&#41;&#58; Results expressed as mean &#40;standard deviation&#41;&#44; initial vs&#46; final&#46;</p><p id="spar0090" class="elsevierStyleSimplePara elsevierViewall">GRLS&#58; scale of severity of symptoms of the International Restless Leg Syndrome Study Group&#59; JH-QoL&#58; John Hopkins restless leg syndrome quality of life&#59; QS&#58; scale of symptoms of lower extremities&#59; SCOPA&#58; sleep habits scale&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="" valign="top" scope="col">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " colspan="2" align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Phase 1</th><th class="td" title="table-head  " colspan="2" align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Phase 2</th></tr><tr title="table-row"><th class="td" title="table-head  " align="" valign="top" scope="col" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Initial&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Final&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Initial&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Final&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">GRLS&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">19&#46;1 &#40;9&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">21&#46;1 &#40;4&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">21&#46;1 &#40;4&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">5&#46;7 &#40;4&#46;6&#41;<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">&#42;</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">QS&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">9&#46;3 &#40;1&#46;7&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">10&#46;2 &#40;2&#46;4&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">10&#46;2 &#40;2&#46;4&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">5&#46;7 &#40;1&#46;1&#41;<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">&#42;</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">JH-QoL&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">19&#46;8 &#40;9&#46;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">22&#46;1 &#40;4&#46;4&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">22&#46;1 &#40;4&#46;4&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">4&#46;3 &#40;4&#46;1&#41;<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">&#42;</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">SCOPA total&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">15&#46;1 &#40;5&#46;3&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">16 &#40;5&#46;3&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">16 &#40;5&#46;3&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">6&#46;7 &#40;1&#46;9&#41;<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">&#42;</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">SCOPA day&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">5&#46;3 &#40;3&#46;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">5&#46;6 &#40;3&#46;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">5&#46;6 &#40;3&#46;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1&#46;4 &#40;0&#46;7&#41;<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">&#42;</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">SCOPA night&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">9&#46;8 &#40;2&#46;7&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">10&#46;4 &#40;2&#46;7&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">10&#46;4 &#40;2&#46;7&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">6&#46;1 &#40;1&#46;1&#41;<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">&#42;</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1672128.png"
              ]
            ]
          ]
          "notaPie" => array:1 [
            0 => array:3 [
              "identificador" => "tblfn0005"
              "etiqueta" => "&#42;"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Statistical significance&#58; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;05&#46;</p>"
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0080" class="elsevierStyleSimplePara elsevierViewall">Scale for severity of symptom &#40;GRLS&#41;&#44; lower extremity symptoms questionnaire &#40;QS&#41;&#44; quality of life related to RLS &#40;JH-QoL&#41; and sleep habits &#40;SCOPA&#41;&#46;</p>"
        ]
      ]
      3 => array:8 [
        "identificador" => "tbl0015"
        "etiqueta" => "Table 3"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at3"
            "detalle" => "Table "
            "rol" => "short"
          ]
        ]
        "tabla" => array:3 [
          "leyenda" => "<p id="spar0100" class="elsevierStyleSimplePara elsevierViewall">Analysis of the mean changes of the main variables between the study groups&#46; Results expressed as mean &#40;standard deviation&#41;&#46;</p><p id="spar0105" class="elsevierStyleSimplePara elsevierViewall">GRLS&#58; scale of severity of symptoms of the International Restless Leg Syndrome Study Group&#59; JH-QoL&#58; John Hopkins restless leg syndrome quality of life&#59; QS&#58; scale of symptoms of lower extremities&#59; SCOPA&#58; sleep habits scale&#46;</p><p id="spar0110" class="elsevierStyleSimplePara elsevierViewall">Analysis using the nonparametric statistical test <span class="elsevierStyleItalic">U</span> of Mann&#8211;Whitney&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="" valign="top" scope="col" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Phase 1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Phase 2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">GRLS&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1&#46;8 &#40;8&#46;5&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">&#8722;13&#46;3 &#40;8&#46;7&#41;<a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">&#42;</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">QS&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;6 &#40;2&#46;4&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">&#8722;4&#46;2 &#40;3&#46;1&#41;<a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">&#42;</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">JH-QoL&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">2&#46;3 &#40;1&#46;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">&#8722;12&#46;7 &#40;3&#46;8&#41;<a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">&#42;</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">SCOPA total&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;9 &#40;0&#46;9&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">&#8722;9&#46;2 &#40;5&#46;3&#41;<a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">&#42;</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">SCOPA day&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;2 &#40;0&#46;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">&#8722;4&#46;1 &#40;3&#46;9&#41;<a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">&#42;</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">SCOPA night&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;6 &#40;0&#46;7&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">&#8722;4&#46;4 &#40;2&#46;3&#41;<a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">&#42;</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1672131.png"
              ]
            ]
          ]
          "notaPie" => array:1 [
            0 => array:3 [
              "identificador" => "tblfn0010"
              "etiqueta" => "&#42;"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0010">Statistical significance&#58; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;05&#46;</p>"
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0095" class="elsevierStyleSimplePara elsevierViewall">Analysis of differences between study groups&#46;</p>"
        ]
      ]
      4 => array:8 [
        "identificador" => "tbl0020"
        "etiqueta" => "Table 4"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at4"
            "detalle" => "Table "
            "rol" => "short"
          ]
        ]
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0120" class="elsevierStyleSimplePara elsevierViewall">CGI&#58; clinical global impression&#59; LQ&#58; quality of life&#59; AE&#58; adverse effects&#59; USA UU&#58; United States&#59; GRLS&#58; symptom severity scale of the International Restless Leg Syndrome Study Group&#59; HD&#58; hemodialysis&#59; iv&#58; intravenous&#59; PLM&#58; periodic leg movements&#59; PSQI&#58; Pittsburgh Sleep Quality Index&#59; RLS-6&#58; Restless Leg Syndrome scale 6&#59; RLS&#58; restless legs syndrome&#59; AVS&#58; analog visual scale&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Author &#40;country&#44; year&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">n</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Intervention groups&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Weeks&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Variables being analyzed&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Main results&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Trenkwalder &#40;Germany&#44; 1995&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">28 &#40;11 HD&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Intervention&#58; madopar &#40;L-dopa 100<span class="elsevierStyleHsp" style=""></span>mg<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>benserazide 25<span class="elsevierStyleHsp" style=""></span>mg&#41;<br>Control&#58; placebo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Own questionnaire on severity of symptoms RLS&#44; PLM&#44; LQ &#40;Hamburger AVS&#41;&#44; CGI&#44; AE&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">L-dopa significantly improved the main variables analyzed&#44; without relevant adverse effects&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Thorp &#40;USA&#44; 2001&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">16&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Intervention&#58; gabapentin &#40;200&#8211;300<span class="elsevierStyleHsp" style=""></span>mg&#47;post-HD day&#41;<br>Control&#58; placebo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Own questionnaire on severity of symptoms&#44; AE&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2 patients abandoned due to lethargy attributed to gabapentin<br>Gabapentin was an effective drug in the treatment of RLS in HD patients&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Sloand &#40;USA&#44; 2004&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">25&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Intervention&#58; Fe dextran iv &#40;1&#46;000<span class="elsevierStyleHsp" style=""></span>mg&#41;<br>Control&#58; normal saline iv&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Severity of symptoms SPI &#40;Rochester&#41;&#44; biochemical data Iron kinetics&#44; AE&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Headache&#44; nausea and vomiting&#44; without differences between groups<br>Iron dextran was associated with improvement of RLS symptoms and elevation of iron levels&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Micozkadioglu &#40;Turkey&#44; 2004&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">15&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Intervention&#58; gabapentin &#40;200<span class="elsevierStyleHsp" style=""></span>mg&#47;post-HD day&#41;<br>Control&#58; levodopa 125<span class="elsevierStyleHsp" style=""></span>mg&#47;day&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">RLS-6&#44; CV &#40;SF-36&#41;&#44; Sleep quality &#40;PSQI&#41;&#44; AE&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">One patient left due to fatigue and syncope in gabapentin group<br>Significant reduction in gabapentin group&#58; RLS-6&#44; SF-36 and PSQI&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Pellecchia &#40;Italy&#44; 2004&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">11&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Intervention&#58; ropinirol &#40;0&#46;25&#8211;2<span class="elsevierStyleHsp" style=""></span>mg&#47;day&#41;<br>Control&#58; levodopa continuous release &#40;25&#47;100&#8211;50&#47;200<span class="elsevierStyleHsp" style=""></span>mg&#47;day&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">GRLS&#44; sleep period &#40;polysomnography&#41;&#44; AE&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Ropinirol was superior to continuous release of levodopa in the treatment of RLS&#44; without relevant AE&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Sagheb &#40;Iran&#44; 2012&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">60&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Intervention&#58; 4 groups of 15 patients&#58; vitamin C &#40;200<span class="elsevierStyleHsp" style=""></span>mg&#41; and vitamin E &#40;400<span class="elsevierStyleHsp" style=""></span>mg&#41;&#59; vitamin C &#40;200<span class="elsevierStyleHsp" style=""></span>mg&#41; and placebo&#59; vitamin E &#40;400<span class="elsevierStyleHsp" style=""></span>mg&#41; and placebo&#59; double blind&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">8&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">GRLS&#44; AE&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Short term improvement of GRLS with Vitamin C and E as well as their combination&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Dauviliers &#40;USA&#44; 2016&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">30&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Intervention rotigotine &#40;1&#8211;3<span class="elsevierStyleHsp" style=""></span>mg&#47;day&#41;<br>Control&#58; placebo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">PLM&#44; GRLS&#44; CGI&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Nausea and dyspepsia in vitamin groups&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1672129.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0115" class="elsevierStyleSimplePara elsevierViewall">Main randomized clinical trials with pharmacological intervention in patients with restless legs syndrome in renal replacement therapy&#46;</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0015"
          "bibliografiaReferencia" => array:25 [
            0 => array:3 [
              "identificador" => "bib0130"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Restless legs syndrome&#47;Willis-Ekbom disease diagnostic criteria&#58; updated International Restless Legs Syndrome Study Group &#40;IRLSSG&#41; consensus criteria &#8211; history&#44; rationale&#44; description&#44; and significance"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "R&#46;P&#46; Allen"
                            1 => "D&#46;L&#46; Picchietti"
                            2 => "D&#46; Garcia-Borreguero"
                            3 => "W&#46;G&#46; Ondo"
                            4 => "A&#46;S&#46; Walters"
                            5 => "J&#46;W&#46; Winkelman"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.sleep.2014.03.025"
                      "Revista" => array:6 [
                        "tituloSerie" => "Sleep Med"
                        "fecha" => "2014"
                        "volumen" => "15"
                        "paginaInicial" => "860"
                        "paginaFinal" => "873"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25023924"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0135"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Definition of restless legs syndrome&#44; how to diagnose it&#44; and how to differentiate it from RLS mimics"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "H&#46; Benes"
                            1 => "A&#46;S&#46; Walters"
                            2 => "R&#46;P&#46; Allen"
                            3 => "W&#46;A&#46; Hening"
                            4 => "R&#46; Kohnen"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/mds.21604"
                      "Revista" => array:7 [
                        "tituloSerie" => "Mov Disord"
                        "fecha" => "2007"
                        "volumen" => "22"
                        "numero" => "Suppl&#46; 18"
                        "paginaInicial" => "S401"
                        "paginaFinal" => "S408"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17566118"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0140"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Prevalence and disease burden of primary restless legs syndrome&#58; results of a general population survey in the United States"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "R&#46;P&#46; Allen"
                            1 => "M&#46; Bharmal"
                            2 => "M&#46; Calloway"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/mds.23430"
                      "Revista" => array:6 [
                        "tituloSerie" => "Mov Disord"
                        "fecha" => "2011"
                        "volumen" => "26"
                        "paginaInicial" => "114"
                        "paginaFinal" => "120"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21322022"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0145"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Restless legs syndrome symptoms in primary care&#58; a prevalence study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "D&#46;A&#46; Nichols"
                            1 => "R&#46;P&#46; Allen"
                            2 => "J&#46;H&#46; Grauke"
                            3 => "J&#46;B&#46; Brown"
                            4 => "M&#46;L&#46; Rice"
                            5 => "P&#46;R&#46; Hyde"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/archinte.163.19.2323"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Intern Med"
                        "fecha" => "2003"
                        "volumen" => "163"
                        "paginaInicial" => "2323"
                        "paginaFinal" => "2329"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14581252"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0150"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Restless legs syndrome&#58; diagnostic criteria&#44; special considerations&#44; and epidemiology&#46; A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "R&#46;P&#46; Allen"
                            1 => "D&#46; Picchietti"
                            2 => "W&#46;A&#46; Hening"
                            3 => "C&#46; Trenkwalder"
                            4 => "A&#46;S&#46; Walters"
                            5 => "J&#46; Montplaisi"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Sleep Med"
                        "fecha" => "2003"
                        "volumen" => "4"
                        "paginaInicial" => "101"
                        "paginaFinal" => "119"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14592341"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0155"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Restless legs syndrome&#47;Willis Ekbom disease&#58; evaluation and treatment"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "R&#46;P&#46; Allen"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.3109/09540261.2014.904279"
                      "Revista" => array:6 [
                        "tituloSerie" => "Int Rev Psychiatry"
                        "fecha" => "2014"
                        "volumen" => "26"
                        "paginaInicial" => "248"
                        "paginaFinal" => "262"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24892899"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0160"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Impact&#44; diagnosis and treatment of restless legs syndrome &#40;RLS&#41; in a primary care population&#58; the REST &#40;RLS epidemiology&#44; symptoms&#44; and treatment&#41; primary care study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "W&#46; Hening"
                            1 => "A&#46;S&#46; Walters"
                            2 => "R&#46;P&#46; Allen"
                            3 => "J&#46; Montplaisir"
                            4 => "A&#46; Myers"
                            5 => "L&#46; Ferini-Strambi"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.sleep.2004.03.006"
                      "Revista" => array:6 [
                        "tituloSerie" => "Sleep Med"
                        "fecha" => "2004"
                        "volumen" => "5"
                        "paginaInicial" => "237"
                        "paginaFinal" => "246"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15165529"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0165"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Restless legs syndrome&#58; a review of clinical and pathophysiologic features"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "R&#46;P&#46; Allen"
                            1 => "C&#46;J&#46; Earley"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Clin Neurophysiol"
                        "fecha" => "2001"
                        "volumen" => "18"
                        "paginaInicial" => "128"
                        "paginaFinal" => "147"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11435804"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0170"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Thalamic glutamate&#47;glutamine in restless legs syndrome&#58; increased and related to disturbed sleep"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "R&#46;P&#46; Allen"
                            1 => "P&#46;B&#46; Barker"
                            2 => "A&#46; Horsk&#225;"
                            3 => "C&#46;J&#46; Earley"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1212/WNL.0b013e318294b3f6"
                      "Revista" => array:6 [
                        "tituloSerie" => "Neurology"
                        "fecha" => "2013"
                        "volumen" => "80"
                        "paginaInicial" => "2028"
                        "paginaFinal" => "2034"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23624560"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0175"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Altered white matter integrity in primary restless legs syndrome patients&#58; diffusion tensor imaging study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "Y&#46; Chang"
                            1 => "J&#46;S&#46; Paik"
                            2 => "H&#46;J&#46; Lee"
                            3 => "H&#46;W&#46; Chang"
                            4 => "H-J&#46; Moon"
                            5 => "R&#46;P&#46; Allen"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1179/1743132814Y.0000000336"
                      "Revista" => array:6 [
                        "tituloSerie" => "Neurol Res"
                        "fecha" => "2014"
                        "volumen" => "36"
                        "paginaInicial" => "769"
                        "paginaFinal" => "774"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24620984"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0180"
              "etiqueta" => "11"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Prevalence and clinical characteristics of restless legs syndrome in diabetic peripheral neuropathy&#58; comparison with chronic osteoarthritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "Y&#46;W&#46; Cho"
                            1 => "G&#46;Y&#46; Na"
                            2 => "J&#46;G&#46; Lim"
                            3 => "S&#46;-H&#46; Kim"
                            4 => "H&#46;S&#46; Kim"
                            5 => "C&#46;J&#46; Earley"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.sleep.2013.09.013"
                      "Revista" => array:6 [
                        "tituloSerie" => "Sleep Med"
                        "fecha" => "2013"
                        "volumen" => "14"
                        "paginaInicial" => "1387"
                        "paginaFinal" => "1392"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24210603"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib0185"
              "etiqueta" => "12"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Ferritin subunits in CSF are decreased in restless legs syndrome"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "S&#46;L&#46; Clardy"
                            1 => "C&#46;J&#46; Earley"
                            2 => "R&#46;P&#46; Allen"
                            3 => "J&#46;L&#46; Beard"
                            4 => "J&#46;R&#46; Connor"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.lab.2005.06.011"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Lab Clin Med"
                        "fecha" => "2006"
                        "volumen" => "147"
                        "paginaInicial" => "67"
                        "paginaFinal" => "73"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16459164"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib0190"
              "etiqueta" => "13"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Clinical characteristics of leg restlessness in Parkinson&#39;s disease compared with idiopathic restless legs syndrome"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "X&#46;-Y&#46; Zhu"
                            1 => "Y&#46; Liu"
                            2 => "X&#46;-J&#46; Zhang"
                            3 => "W&#46;-H&#46; Yang"
                            4 => "Y&#46; Feng"
                            5 => "W&#46;G&#46; Ondo"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jns.2015.07.008"
                      "Revista" => array:7 [
                        "tituloSerie" => "J Neurol Sci"
                        "fecha" => "2015"
                        "volumen" => "357"
                        "numero" => "1&#8211;2"
                        "paginaInicial" => "109"
                        "paginaFinal" => "114"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26189051"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib0195"
              "etiqueta" => "14"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A 10-year&#44; longitudinal assessment of dopamine agonists and methadone in the treatment of restless legs syndrome"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "N&#46; Silver"
                            1 => "R&#46;P&#46; Allen"
                            2 => "J&#46; Senerth"
                            3 => "C&#46;J&#46; Earley"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.sleep.2010.11.002"
                      "Revista" => array:6 [
                        "tituloSerie" => "Sleep Med"
                        "fecha" => "2011"
                        "volumen" => "12"
                        "paginaInicial" => "440"
                        "paginaFinal" => "444"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21239226"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib0200"
              "etiqueta" => "15"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Guidelines for the first-line treatment of restless legs syndrome&#47;Willis-Ekbom disease&#44; prevention and treatment of dopaminergic augmentation&#58; a combined task force of the IRLSSG&#44; EURLSSG&#44; and the RLS-foundation"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "D&#46; Garcia-Borreguero"
                            1 => "M&#46;H&#46; Silber"
                            2 => "J&#46;W&#46; Winkelman"
                            3 => "B&#46; H&#246;gl"
                            4 => "J&#46; Bainbridge"
                            5 => "M&#46; Buchfuhrer"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.sleep.2016.01.017"
                      "Revista" => array:6 [
                        "tituloSerie" => "Sleep Med"
                        "fecha" => "2016"
                        "volumen" => "21"
                        "paginaInicial" => "1"
                        "paginaFinal" => "11"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27448465"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib0205"
              "etiqueta" => "16"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Clinical efficacy of ropinirole for restless legs syndrome is not affected by age at symptom onset"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "R&#46;P&#46; Allen"
                            1 => "S&#46;Y&#46; Ritchie"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.sleep.2007.08.017"
                      "Revista" => array:6 [
                        "tituloSerie" => "Sleep Med"
                        "fecha" => "2008"
                        "volumen" => "9"
                        "paginaInicial" => "899"
                        "paginaFinal" => "902"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18024167"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            16 => array:3 [
              "identificador" => "bib0210"
              "etiqueta" => "17"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy and augmentation during 6 months of double-blind pramipexole for restless legs syndrome"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "B&#46; H&#246;gl"
                            1 => "D&#46; Garcia-Borreguero"
                            2 => "C&#46; Trenkwalder"
                            3 => "L&#46; Ferini-Strambi"
                            4 => "W&#46; Hening"
                            5 => "W&#46; Poewe"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.sleep.2010.12.007"
                      "Revista" => array:6 [
                        "tituloSerie" => "Sleep Med"
                        "fecha" => "2011"
                        "volumen" => "12"
                        "paginaInicial" => "351"
                        "paginaFinal" => "360"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21354368"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            17 => array:3 [
              "identificador" => "bib0215"
              "etiqueta" => "18"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Rotigotine improves restless legs syndrome&#58; a 6-month randomized&#44; double-blind&#44; placebo-controlled trial in the United States"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "W&#46;A&#46; Hening"
                            1 => "R&#46;P&#46; Allen"
                            2 => "W&#46;G&#46; Ondo"
                            3 => "A&#46;S&#46; Walters"
                            4 => "J&#46;W&#46; Winkelman"
                            5 => "P&#46; Becker"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/mds.23157"
                      "Revista" => array:6 [
                        "tituloSerie" => "Mov Disord"
                        "fecha" => "2010"
                        "volumen" => "25"
                        "paginaInicial" => "1675"
                        "paginaFinal" => "1683"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20629075"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            18 => array:3 [
              "identificador" => "bib0220"
              "etiqueta" => "19"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Relation of the International Restless Legs Syndrome Study Group rating scale with the Clinical Global Impression Severity Scale&#44; the Restless Legs Syndrome 6-Item Questionnaire&#44; and the Restless Legs Syndrome-Quality of life Questionnaire"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "R&#46; Allen"
                            1 => "W&#46; Oertel"
                            2 => "A&#46; Walters"
                            3 => "H&#46; Benes"
                            4 => "E&#46; Schollmayer"
                            5 => "F&#46; Grieger"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.sleep.2013.09.008"
                      "Revista" => array:6 [
                        "tituloSerie" => "Sleep Med"
                        "fecha" => "2013"
                        "volumen" => "14"
                        "paginaInicial" => "1375"
                        "paginaFinal" => "1380"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24246378"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            19 => array:3 [
              "identificador" => "bib0225"
              "etiqueta" => "20"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The Johns Hopkins telephone diagnostic interview for the restless legs syndrome&#58; preliminary investigation for validation in a multi-center patient and control population"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "W&#46;A&#46; Hening"
                            1 => "R&#46;P&#46; Allen"
                            2 => "S&#46; Thanner"
                            3 => "T&#46; Washburn"
                            4 => "D&#46; Heckler"
                            5 => "A&#46;S&#46; Walters"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Sleep Med"
                        "fecha" => "2003"
                        "volumen" => "4"
                        "paginaInicial" => "137"
                        "paginaFinal" => "141"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14592344"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            20 => array:3 [
              "identificador" => "bib0230"
              "etiqueta" => "21"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The Swedish SCOPA-SLEEP for assessment of sleep disorders in Parkinson&#39;s disease and healthy controls"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "P&#46; Hagell"
                            1 => "A&#46; Westergren"
                            2 => "S&#46; Janelidze"
                            3 => "O&#46; Hansson"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s11136-016-1318-2"
                      "Revista" => array:6 [
                        "tituloSerie" => "Qual Life Res"
                        "fecha" => "2016"
                        "volumen" => "25"
                        "paginaInicial" => "2571"
                        "paginaFinal" => "2577"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27198749"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            21 => array:3 [
              "identificador" => "bib0235"
              "etiqueta" => "22"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Restless legs syndrome prevalence and impact&#58; REST general population study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "R&#46;P&#46; Allen"
                            1 => "A&#46;S&#46; Walters"
                            2 => "J&#46; Montplaisir"
                            3 => "W&#46; Hening"
                            4 => "A&#46; Myers"
                            5 => "T&#46;J&#46; Bell"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/archinte.165.11.1286"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Intern Med"
                        "fecha" => "2005"
                        "volumen" => "165"
                        "paginaInicial" => "1286"
                        "paginaFinal" => "1292"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15956009"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            22 => array:3 [
              "identificador" => "bib0240"
              "etiqueta" => "23"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Interventions for chronic kidney disease-associated restless legs syndrome"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "S&#46; Gopaluni"
                            1 => "M&#46; Sherif"
                            2 => "N&#46;A&#46; Ahmadouk"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/14651858.CD011360.pub2"
                      "Revista" => array:4 [
                        "tituloSerie" => "Cochrane Database Syst Rev"
                        "fecha" => "2016"
                        "volumen" => "11"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27886368"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            23 => array:3 [
              "identificador" => "bib0245"
              "etiqueta" => "24"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Clinical pharmacology and efficacy of rotigotine &#40;Neupro<span class="elsevierStyleSup">&#174;</span> patch&#41; in the treatment of restless leg syndrome"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "L&#46; Ferini-Strambi"
                            1 => "S&#46; Marelli"
                            2 => "A&#46; Galbiati"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1080/17425255.2016.1194393"
                      "Revista" => array:6 [
                        "tituloSerie" => "Expert Opin Drug Metab Toxicol"
                        "fecha" => "2016"
                        "volumen" => "12"
                        "paginaInicial" => "967"
                        "paginaFinal" => "975"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27224246"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            24 => array:3 [
              "identificador" => "bib0250"
              "etiqueta" => "25"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Rotigotine in hemodialysis-associated restless legs syndrome&#58; a randomized controlled trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "Y&#46; Dauvilliers"
                            1 => "H&#46; Benes"
                            2 => "M&#46; Partinen"
                            3 => "V&#46; Rauta"
                            4 => "D&#46; Rifkin"
                            5 => "E&#46; Dohin"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1053/j.ajkd.2015.12.027"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Kidney Dis"
                        "fecha" => "2016"
                        "volumen" => "68"
                        "paginaInicial" => "434"
                        "paginaFinal" => "443"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26851201"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/20132514/0000003800000001/v1_201802180616/S2013251417302079/v1_201802180616/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "42660"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Original articles"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/20132514/0000003800000001/v1_201802180616/S2013251417302079/v1_201802180616/en/main.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251417302079?idApp=UINPBA000064"
]
Article information
ISSN: 20132514
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 9 11 20
2024 October 53 38 91
2024 September 64 22 86
2024 August 69 57 126
2024 July 51 34 85
2024 June 87 48 135
2024 May 67 40 107
2024 April 44 33 77
2024 March 57 19 76
2024 February 41 29 70
2024 January 51 24 75
2023 December 40 23 63
2023 November 55 31 86
2023 October 53 31 84
2023 September 58 31 89
2023 August 46 28 74
2023 July 74 30 104
2023 June 69 23 92
2023 May 96 27 123
2023 April 66 16 82
2023 March 76 25 101
2023 February 75 23 98
2023 January 65 27 92
2022 December 99 39 138
2022 November 87 48 135
2022 October 93 38 131
2022 September 81 42 123
2022 August 84 51 135
2022 July 90 44 134
2022 June 85 48 133
2022 May 75 35 110
2022 April 82 64 146
2022 March 75 59 134
2022 February 69 40 109
2022 January 56 41 97
2021 December 41 42 83
2021 November 40 39 79
2021 October 61 44 105
2021 September 35 38 73
2021 August 32 37 69
2021 July 38 46 84
2021 June 33 34 67
2021 May 60 43 103
2021 April 156 53 209
2021 March 70 36 106
2021 February 90 38 128
2021 January 88 26 114
2020 December 74 22 96
2020 November 42 18 60
2020 October 43 24 67
2020 September 45 16 61
2020 August 42 21 63
2020 July 44 16 60
2020 June 38 26 64
2020 May 42 14 56
2020 April 60 24 84
2020 March 52 30 82
2020 February 41 25 66
2020 January 58 28 86
2019 December 82 31 113
2019 November 82 37 119
2019 October 71 34 105
2019 September 53 26 79
2019 August 43 25 68
2019 July 41 33 74
2019 June 51 26 77
2019 May 51 26 77
2019 April 144 57 201
2019 March 57 28 85
2019 February 37 28 65
2019 January 28 30 58
2018 December 147 59 206
2018 November 330 31 361
2018 October 249 12 261
2018 September 147 28 175
2018 August 91 22 113
2018 July 84 19 103
2018 June 74 10 84
2018 May 117 12 129
2018 April 89 12 101
2018 March 81 9 90
2018 February 66 9 75
2018 January 40 11 51
2017 December 28 3 31
Show all

Follow this link to access the full text of the article

Idiomas
Nefrología (English Edition)
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?